Acute flaccid myelitis (AFM) is a rare, acute, polio-like neurologic syndrome, mainly reported in children, with rapid flaccid limb weakness and spinal cord gray-matter involvement. Most cases follow a febrile or respiratory prodrome. The clinical syndrome localizes predominantly to lower motor neurons in the anterior horn of the spinal cord, can involve cranial, bulbar, axial, and respiratory muscles, and is strongly associated epidemiologically with non-polio enteroviruses, especially enterovirus D68.
Ask a research question about Acute Flaccid Myelitis. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).
Do not include personal health information in your question. Questions and results are cached in your browser's local storage.
Conditions with similar clinical presentations that must be differentiated from Acute Flaccid Myelitis:
name: Acute Flaccid Myelitis
creation_date: "2026-05-16T17:34:01Z"
category: Neurological Disorder
disease_term:
preferred_term: acute flaccid myelitis
term:
id: MONDO:0100115
label: acute flaccid myelitis
parents:
- Myelitis
- Acute disease
- Central nervous system disorder
description: >-
Acute flaccid myelitis (AFM) is a rare, acute, polio-like neurologic
syndrome, mainly reported in children, with rapid flaccid limb weakness and
spinal cord gray-matter involvement. Most cases follow a febrile or
respiratory prodrome. The clinical syndrome localizes predominantly to lower
motor neurons in the anterior horn of the spinal cord, can involve cranial,
bulbar, axial, and respiratory muscles, and is strongly associated
epidemiologically with non-polio enteroviruses, especially enterovirus D68.
external_assertions:
- name: Orphanet acute flaccid myelitis record
source: Orphanet
assertion_type: structured_disease_record
external_id: ORPHA:623801
url: http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=623801
description: >-
Orphanet's ORPHA:623801 structured record for acute flaccid myelitis
provides the rare-disease identifier, exact MONDO cross-reference, narrower
ICD-10 mapping, MeSH and UMLS cross-references, broad onset categories, and
international incidence annotations used to cross-check this entry.
evidence:
- reference: ORPHA:623801
reference_title: Acute flaccid myelitis
supports: SUPPORT
evidence_source: OTHER
snippet: "MONDO:0100115 | Exact"
explanation: >-
Orphanet maps ORPHA:623801 exactly to the MONDO disease identifier used by
this entry.
- reference: ORPHA:623801
reference_title: Acute flaccid myelitis
supports: SUPPORT
evidence_source: OTHER
snippet: "ICD-10:G04.8 | Narrower"
explanation: >-
The Orphanet cross-reference table records a narrower ICD-10 mapping for
AFM.
definitions:
- name: Clinical and radiologic AFM syndrome
definition_type: CASE_DEFINITION
description: >-
AFM is defined clinically by acute flaccid limb weakness with objective
evidence of spinal cord gray-matter involvement, typically by MRI, and/or
supporting cerebrospinal-fluid inflammation after exclusion of mimics such
as Guillain-Barre syndrome, spinal cord infarction, poliomyelitis, and
transverse myelitis.
criteria_sets:
- name: Core AFM features
core_clinical_characteristics:
- preferred_term: acute flaccid limb weakness
term:
id: HP:0003690
label: Limb muscle weakness
description: Rapid onset limb weakness with lower motor neuron features.
- preferred_term: spinal cord gray matter lesion
term:
id: HP:0100561
label: Spinal cord lesion
description: >-
MRI lesion centered in spinal cord gray matter, especially the anterior
horns.
- preferred_term: CSF pleocytosis
term:
id: HP:0012229
label: CSF pleocytosis
description: >-
Supportive inflammatory cerebrospinal-fluid finding in probable or
definite AFM criteria.
evidence:
- reference: PMID:31409689
reference_title: Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Classification criteria for a confirmed AFM case are acute flaccid limb
weakness and magnetic resonance imaging evidence of a predominantly gray
matter lesion that spans at least one spinal segment
explanation: >-
This reproduces the surveillance definition for confirmed AFM and
directly supports the two required core criteria.
evidence:
- reference: PMID:27422805
reference_title: "Acute flaccid myelitis: A clinical review of US cases 2012-2015."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "acute flaccid limb weakness with spinal cord gray matter lesions"
explanation: >-
The US case review directly supports the core clinical-radiologic
definition used here.
- reference: PMID:33357469
reference_title: "Acute flaccid myelitis: cause, diagnosis, and management."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "no single sensitive and specific test for AFM"
explanation: >-
The Lancet review supports modeling AFM as a syndromic diagnosis requiring
integrated clinical, MRI, CSF, and exclusionary evidence.
infectious_agent:
- name: Enterovirus D68
infectious_agent_term:
preferred_term: Enterovirus D68
term:
id: NCBITaxon:42789
label: Enterovirus D68
description: >-
EV-D68 is the best-supported infectious exposure associated with epidemic
AFM. Temporal clustering, respiratory detections, CSF enterovirus-antibody
enrichment, animal causation, and human neural-model infection support a
causal role, but viral RNA is rarely found in CSF and not every AFM case is
attributable to EV-D68.
evidence:
- reference: PMID:31409689
reference_title: Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "antibodies to EV peptides were present in CSF of 11 of 14 AFM patients (79%)"
explanation: >-
CSF enterovirus-antibody enrichment supplies biologic evidence of prior
enterovirus exposure when viral nucleic acid is no longer detectable.
- reference: PMID:31409689
reference_title: Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "EV RNA was confirmed in CSF from only 1 adult AFM case"
explanation: >-
Rare direct CSF detection is important negative context: it limits
patient-level etiologic confirmation despite the broader association.
- reference: PMID:42066114
reference_title: "Enterovirus D68 and Acute Neurologic Outcomes: A Systematic Review and Meta-Analysis (2010-2025)."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "AFM case-control studies did not (OR 0.86, 95% CI 0.40-1.86, k = 20)"
explanation: >-
The 2026 meta-analysis finds design-dependent and heterogeneous estimates,
preventing a simplistic claim that EV-D68 explains every AFM case.
- name: Enterovirus A71
infectious_agent_term:
preferred_term: Enterovirus A71
term:
id: NCBITaxon:39054
label: Enterovirus A71
description: >-
EV-A71 is a recognized non-polio enterovirus associated with some AFM cases,
but it is not the principal explanation for the recent North American
biennial AFM pattern. Viral association is represented here as an agent
relationship rather than as a formal disease subtype.
evidence:
- reference: PMID:36268734
reference_title: "Epidemiology of acute flaccid myelitis in children in the Netherlands, 2014 to 2019."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "EV-D68 and EV-A71"
explanation: >-
The surveillance report identifies both viruses among non-polio
enteroviruses associated with AFM.
mechanistic_hypotheses:
- hypothesis_group_id: ev_d68_direct_neuroinvasion_model
hypothesis_label: EV-D68 Direct Neuroinvasion Model
status: CANONICAL
description: >-
In the best-supported model for epidemic AFM, EV-D68 respiratory infection
is followed rarely by CNS access, receptor-mediated infection of spinal
neural cells, and anterior-horn motor-neuron injury. Epidemiologic and human
CSF evidence support the association, while mouse and organoid systems show
that contemporary EV-D68 strains can infect neural tissue and cause
paralytic myelitis. The model does not imply virologic confirmation in every
patient.
evidence:
- reference: PMID:28231269
reference_title: A mouse model of paralytic myelitis caused by enterovirus D68.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Virus isolated from spinal cords of infected mice transmitted disease when injected into naïve mice, fulfilling Koch's postulates in this model."
explanation: >-
Experimental transmission establishes direct causation in the mouse model,
while the qualification "in this model" prevents overextension to humans.
- reference: PMID:33357469
reference_title: "Acute flaccid myelitis: cause, diagnosis, and management."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "the disease appears to be caused by non-polio enterovirus infection"
explanation: >-
The clinical review identifies non-polio enterovirus infection as the
leading human etiologic model.
- hypothesis_group_id: secondary_immune_mediated_injury_model
hypothesis_label: Secondary Immune-Mediated Neural Injury Model
status: EMERGING
description: >-
Direct neural infection may initiate AFM without being sufficient to cause
the full motor-neuron injury. Persistent productive infection with little
cytopathic effect in human spinal-cord organoids suggests that host immune
responses or other secondary injury mechanisms may contribute to neuronal
loss.
evidence:
- reference: DOI:10.1128/mbio.01058-23
reference_title: Contemporary enterovirus-D68 isolates infect human spinal cord organoids
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
EV-D68 infection is not the sole mediator of neuronal cell death in the
spinal cord in those with AFM and that secondary injury from the immune
response likely contributes to pathogenesis.
explanation: >-
The human organoid study explicitly proposes secondary immune injury after
observing prolonged productive infection without appreciable cytopathy.
epidemiology:
- name: Rare pediatric disease with biennial outbreaks
description: >-
AFM is rare, occurs mainly in children, and has shown seasonal biennial
outbreak peaks in the United States and other regions since 2012.
evidence:
- reference: PMID:33357469
reference_title: "Acute flaccid myelitis: cause, diagnosis, and management."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "mainly affecting children"
explanation: >-
The Lancet review summarizes AFM as a mainly pediatric polio-like illness.
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "every 2 years since 2012"
explanation: >-
This clinical review describes the US biennial seasonal peak pattern.
- name: United States surveillance since the 2018 peak
description: >-
CDC surveillance found only 28-47 confirmed US AFM cases per year during
2019-2022. Counts remained low despite increased EV-D68 circulation in 2022,
showing that respiratory-virus circulation alone does not reliably predict
AFM burden and that additional host, viral, or exposure factors are likely.
evidence:
- reference: PMID:38300829
reference_title: "Surveillance for Acute Flaccid Myelitis - United States, 2018-2022."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The number of AFM cases was low during 2019-2022 (28-47 cases per year)"
explanation: >-
The CDC surveillance report supplies the post-2018 annual range.
- reference: PMID:38300829
reference_title: "Surveillance for Acute Flaccid Myelitis - United States, 2018-2022."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "the number of cases remained low in 2022 despite evidence of increased EV-D68 circulation in the United States"
explanation: >-
The discordance between respiratory circulation and paralysis motivates
explicit uncertainty about the determinants of neuroinvasive disease.
- name: Netherlands pediatric incidence
description: >-
Retrospective multicenter surveillance in the Netherlands found a very low
mean pediatric AFM incidence during 2014-2019.
minimum_value: 0.06
unit: cases per 100000 children per year
evidence:
- reference: PMID:36268734
reference_title: "Epidemiology of acute flaccid myelitis in children in the Netherlands, 2014 to 2019."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "0.06/100,000 children/year"
explanation: >-
The Dutch cohort reports the pediatric mean incidence estimate encoded
here.
- name: Orphanet onset spectrum
description: >-
Orphanet records AFM onset across infancy, childhood, adolescence, and
adulthood, consistent with a predominantly pediatric disorder that can also
occur outside childhood.
evidence:
- reference: ORPHA:623801
reference_title: Acute flaccid myelitis
supports: SUPPORT
evidence_source: OTHER
snippet: "Age of onset: Childhood"
explanation: >-
Orphanet records childhood onset among AFM natural-history categories.
- reference: ORPHA:623801
reference_title: Acute flaccid myelitis
supports: SUPPORT
evidence_source: OTHER
snippet: "Age of onset: Adult"
explanation: >-
Orphanet also records adult onset, supporting a broad age range despite
pediatric predominance.
- name: Population-based pediatric risk factors
description: >-
A closed-population pediatric cohort identified male sex, Asian ancestry,
asthma or atopic dermatitis history, and head injury history as AFM risk
factors. These associations support host-susceptibility modeling but do not
establish a Mendelian or deterministic risk mechanism.
evidence:
- reference: PMID:30985511
reference_title: "Incidence, Risk Factors and Outcomes Among Children With Acute Flaccid Myelitis: A Population-based Cohort Study in a California Health Network Between 2011 and 2016."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Risk factors included male sex, Asian ancestry and history of asthma, atopic dermatitis or head injury."
explanation: >-
The California population-based cohort provides the specific risk-factor
associations summarized here.
- name: European EV-D68-associated AFM surveillance
description: >-
A European ENPEN survey found 130 reported AFM cases across 14 countries
during 2016-2023, including 48 EV-D68-laboratory-confirmed cases; most
occurred in years of increased EV-D68 circulation. The same report cautions
that structural AFM surveillance was limited, so counts should be
interpreted as incomplete surveillance data.
evidence:
- reference: PMID:40444374
reference_title: "Acute flaccid myelitis in Europe between 2016 and 2023: indicating the need for better registration."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The survey revealed 130 AFM cases for 14 countries, with 48 (37%) EV-D68-laboratory-confirmed."
explanation: >-
The European survey directly supports the cross-country case count and
EV-D68-confirmed subset.
- reference: PMID:40444374
reference_title: "Acute flaccid myelitis in Europe between 2016 and 2023: indicating the need for better registration."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "70% (n = 91) occurred in 2016, 2018 and 2022, when EV-D68 circulation increased."
explanation: >-
This supports the temporal association between AFM occurrence and
increased EV-D68 circulation in Europe.
environmental:
- name: EV-D68 respiratory circulation and wastewater seasonality
presence: PRESENT
description: >-
EV-D68 circulation is the main environmental infectious exposure context for
AFM surveillance. Wastewater monitoring can detect EV-D68 seasonality and
regional timing before or alongside clinical respiratory diagnoses, which
may help public-health preparedness even though AFM remains rare relative to
EV-D68 infection.
effect: >-
Increased EV-D68 circulation raises concern for AFM preparedness but is not
sufficient on its own to predict individual paralysis risk.
evidence:
- reference: PMID:41853773
reference_title: "Enterovirus D68 in United States wastewater: a longitudinal surveillance study integrating climatic, demographic, and clinical data."
supports: SUPPORT
evidence_source: OTHER
snippet: "Enterovirus D68 (EV-D68) can cause severe respiratory illness and acute flaccid myelitis (AFM)"
explanation: >-
The wastewater surveillance study frames EV-D68 as a respiratory pathogen
relevant to AFM preparedness.
- reference: PMID:41853773
reference_title: "Enterovirus D68 in United States wastewater: a longitudinal surveillance study integrating climatic, demographic, and clinical data."
supports: SUPPORT
evidence_source: OTHER
snippet: "We observed a biennial EV-D68 pattern with a national peak in September 2024"
explanation: >-
Wastewater data support the seasonal and biennial environmental
circulation pattern encoded here.
pathophysiology:
- name: Non-polio Enterovirus Respiratory Infection
description: >-
AFM most often occurs after a respiratory or febrile illness. EV-D68 is the
leading epidemic-associated virus. Only a very small fraction of respiratory
infections are followed by AFM, and the route and determinants that permit
subsequent CNS access in children remain unresolved.
locations:
- preferred_term: respiratory system
term:
id: UBERON:0001004
label: respiratory system
- preferred_term: central nervous system
term:
id: UBERON:0001017
label: central nervous system
biological_processes:
- preferred_term: response to virus
modifier: INCREASED
term:
id: GO:0009615
label: response to virus
evidence:
- reference: PMID:33357469
reference_title: "Acute flaccid myelitis: cause, diagnosis, and management."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "the disease appears to be caused by non-polio enterovirus infection"
explanation: >-
This clinical synthesis supports the enterovirus model while appropriately
using probabilistic wording.
- reference: PMID:31409689
reference_title: Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The cause of AFM remains elusive. An infectious agent is only rarely detected in cerebrospinal fluid (CSF)."
explanation: >-
Direct human etiologic confirmation is uncommon and the graph therefore
does not represent neuroinvasion as proven in every case.
downstream:
- target: Prodromal respiratory tract infection
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
hypothesis_groups:
- ev_d68_direct_neuroinvasion_model
description: >-
Respiratory enterovirus infection commonly produces the febrile or
respiratory prodrome that precedes neurologic weakness.
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "In most cases, prodromal fever or respiratory symptoms occur"
explanation: The review links the prodrome temporally to AFM onset.
- target: MFSD6- and ICAM5-Mediated EV-D68 Neural Cell Entry
causal_link_type: INDIRECT_UNKNOWN_INTERMEDIATES
hypothesis_groups:
- ev_d68_direct_neuroinvasion_model
description: >-
Respiratory infection precedes rare CNS access and neural-cell entry, but
the route of spread and other intervening determinants are not established.
evidence:
- reference: PMID:40132641
reference_title: MFSD6 is an entry receptor for enterovirus D68.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "MFSD6 as a host entry factor for EV-D68"
explanation: The receptor study establishes the downstream entry step.
- name: MFSD6- and ICAM5-Mediated EV-D68 Neural Cell Entry
description: >-
MFSD6 is a directly demonstrated EV-D68 entry receptor in respiratory and
neural primary cells. ICAM5 is a proposed neuron-specific receptor and is
retained as complementary, lower-tier evidence rather than treated as a
universal AFM receptor mechanism.
genes:
- preferred_term: MFSD6
term:
id: hgnc:24711
label: MFSD6
- preferred_term: ICAM5
term:
id: hgnc:5348
label: ICAM5
biological_processes:
- preferred_term: symbiont entry into host cell
modifier: INCREASED
term:
id: GO:0046718
label: symbiont entry into host cell
evidence:
- reference: PMID:40132641
reference_title: MFSD6 is an entry receptor for enterovirus D68.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "Knockout of MFSD6 expression abrogated EV-D68 infection in cell lines and primary cells corresponding to respiratory and neural cells."
explanation: >-
Genetic loss-of-function and primary-cell experiments directly support
MFSD6-dependent entry.
- reference: PMID:41467840
reference_title: "Enterovirus D68 receptor usage: from static attachment to dynamic entry."
supports: SUPPORT
evidence_source: OTHER
snippet: "ICAM-5) as a neuron-specific receptor that provides a molecular explanation for neurotropism in AFM."
explanation: >-
A receptor-usage review supports ICAM5 as a neuron-specific alternative,
but this is weaker evidence than the MFSD6 perturbation experiments.
downstream:
- target: Spinal Neural Cell Tropism and Infection
causal_link_type: DIRECT
hypothesis_groups:
- ev_d68_direct_neuroinvasion_model
description: >-
Receptor-dependent cell entry permits productive EV-D68 infection in
susceptible neural cells.
evidence:
- reference: PMID:40132641
reference_title: MFSD6 is an entry receptor for enterovirus D68.
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "MFSD6 localized to the plasma membrane and was required for viral entry into host cells."
explanation: This directly links receptor availability to viral entry.
- name: Spinal Neural Cell Tropism and Infection
description: >-
Contemporary EV-D68 strains productively infect human spinal-cord organoids.
Tropism differs by strain across neurons, cycling astrocytes, and
oligodendrocyte precursor cells, indicating that neural susceptibility is
neither uniform nor explained by motor neurons alone.
locations:
- preferred_term: spinal cord
term:
id: UBERON:0002240
label: spinal cord
cell_types:
- preferred_term: motor neuron
term:
id: CL:0000100
label: motor neuron
- preferred_term: astrocyte
term:
id: CL:0000127
label: astrocyte
- preferred_term: oligodendrocyte precursor cell
term:
id: CL:0002453
label: oligodendrocyte precursor cell
evidence:
- reference: DOI:10.1128/mbio.01058-23
reference_title: Contemporary enterovirus-D68 isolates infect human spinal cord organoids
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "productively infected with contemporary strains, but not a historic strain, of EV-D68"
explanation: >-
Productive infection in human spinal-cord organoids establishes direct
human-cell neural tropism and a strain effect.
- reference: DOI:10.3389/fmicb.2025.1698639
reference_title: Strain-specific tropism and transcriptional responses of enterovirus D68 infection in human spinal cord organoids
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "distinct viral tropism and host transcriptional responses"
explanation: Single-cell profiling supports strain- and cell-type-specific tropism.
downstream:
- target: Spinal Gray Matter Inflammation and Motor Neuron Injury
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
hypothesis_groups:
- ev_d68_direct_neuroinvasion_model
- secondary_immune_mediated_injury_model
description: >-
Neural infection can precede motor-neuron injury through direct viral
effects and/or secondary inflammatory injury; their relative contribution
in human AFM remains unresolved.
evidence:
- reference: DOI:10.1128/mbio.01058-23
reference_title: Contemporary enterovirus-D68 isolates infect human spinal cord organoids
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "secondary injury from the immune response likely contributes to pathogenesis"
explanation: >-
Organoid infection with limited cytopathy specifically supports an
intervening secondary-injury mechanism.
- reference: PMID:28231269
reference_title: A mouse model of paralytic myelitis caused by enterovirus D68.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "infection and loss of motor neurons in the anterior horns of spinal cord segments corresponding to paralyzed limbs."
explanation: The mouse model links spinal infection to regional motor-neuron loss.
- name: Spinal Gray Matter Inflammation and Motor Neuron Injury
description: >-
AFM injury is centered on spinal gray matter and anterior-horn motor neurons.
Cranial motor nuclei can also be involved, accounting for facial, bulbar,
and respiratory manifestations that cannot be attributed to spinal anterior
horns alone.
locations:
- preferred_term: ventral horn of spinal cord
term:
id: UBERON:0002257
label: ventral horn of spinal cord
- preferred_term: brainstem
term:
id: UBERON:0002298
label: brainstem
cell_types:
- preferred_term: anterior horn motor neuron
term:
id: CL:2000048
label: anterior horn motor neuron
biological_processes:
- preferred_term: inflammatory response
modifier: INCREASED
term:
id: GO:0006954
label: inflammatory response
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "The primary site of injury in AFM is the anterior horn cells of the spinal cord"
explanation: The clinical review identifies the principal anatomic lesion.
downstream:
- target: Spinal cord gray matter lesion
causal_link_type: DIRECT
description: >-
Gray-matter injury is visualized as the characteristic spinal-cord MRI
abnormality.
evidence:
- reference: PMID:26720027
reference_title: "Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Fifty-six patients had T2 hyperintensity of spinal gray matter on magnetic resonance imaging"
explanation: The clinical series directly links the lesion compartment to MRI signal.
- target: CSF pleocytosis
causal_link_type: INDIRECT_KNOWN_INTERMEDIATES
hypothesis_groups:
- secondary_immune_mediated_injury_model
description: >-
CNS inflammation can increase leukocytes in CSF, although pleocytosis is
supportive rather than required or disease-specific.
evidence:
- reference: PMID:26720027
reference_title: "Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "43 patients had cerebrospinal fluid pleocytosis"
explanation: The case series quantifies the inflammatory CSF finding.
- target: Segmental and Cranial Lower Motor Neuron Dysfunction
causal_link_type: DIRECT
description: >-
Loss or dysfunction of spinal and cranial motor neurons produces the
characteristic lower-motor-neuron syndrome.
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "resulting in a motor neuronopathy"
explanation: The clinical review explicitly links anterior-horn injury to motor neuronopathy.
- name: Segmental and Cranial Lower Motor Neuron Dysfunction
description: >-
Dysfunction of segmental anterior-horn and cranial motor systems produces
rapid flaccid weakness, depressed reflexes, asymmetry, and, when brainstem or
respiratory motor pools are affected, facial, bulbar, or ventilatory
impairment.
locations:
- preferred_term: ventral horn of spinal cord
term:
id: UBERON:0002257
label: ventral horn of spinal cord
- preferred_term: brainstem
term:
id: UBERON:0002298
label: brainstem
cell_types:
- preferred_term: motor neuron
term:
id: CL:0000100
label: motor neuron
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Respiratory, axial, bulbar, facial, and extraocular muscles may also be affected."
explanation: This defines the motor distribution beyond limb weakness.
downstream:
- target: Acute flaccid paralysis
causal_link_type: DIRECT
description: Motor-neuron dysfunction produces acute flaccid paralysis.
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "characterized by acute flaccid paralysis"
explanation: The review directly describes the resulting paralysis phenotype.
- target: Acute limb weakness
causal_link_type: DIRECT
description: Segmental motor-neuron dysfunction produces abrupt limb weakness.
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "acute-onset flaccid limb weakness"
explanation: The review directly describes the core limb phenotype.
- target: Asymmetric limb weakness
causal_link_type: DIRECT
description: Patchy segmental motor-pool injury often produces asymmetric weakness.
evidence:
- reference: PMID:34747551
reference_title: "Acute flaccid myelitis and Guillain-Barré syndrome in children: A comparative study with evaluation of diagnostic criteria."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "asymmetric limb weakness (58% vs. 0%, p < 0.001)"
explanation: The comparative cohort quantifies the asymmetric pattern.
- target: Areflexia
causal_link_type: DIRECT
description: Lower-motor-neuron dysfunction interrupts the reflex arc.
evidence:
- reference: PMID:39163469
reference_title: Acute Flaccid Myelitis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "decreased or absent reflexes"
explanation: The clinical summary describes the lower-motor-neuron reflex finding.
- target: Cranial nerve palsy
causal_link_type: DIRECT
description: Cranial motor-system involvement can produce cranial neuropathies.
evidence:
- reference: PMID:31014167
reference_title: "Acute Flaccid Myelitis Associated With Enterovirus D68: A Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "with cranial neuropathy"
explanation: The review documents cranial neuropathy in AFM.
- target: Facial weakness
causal_link_type: DIRECT
description: Facial motor involvement can cause weakness of facial musculature.
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "bulbar, facial, and extraocular muscles may also be affected"
explanation: The review directly includes facial motor involvement.
- target: Bulbar palsy
causal_link_type: DIRECT
description: Brainstem motor involvement can impair bulbar function.
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Respiratory, axial, bulbar, facial, and extraocular muscles may also be affected."
explanation: The review directly includes bulbar involvement.
- target: Respiratory insufficiency due to muscle weakness
causal_link_type: DIRECT
description: Respiratory motor-pool involvement can cause ventilatory failure.
evidence:
- reference: PMID:33357469
reference_title: "Acute flaccid myelitis: cause, diagnosis, and management."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "can invoke respiratory failure and other critical complications"
explanation: The clinical review links profound motor weakness to respiratory failure.
phenotypes:
- name: Prodromal respiratory tract infection
category: Respiratory
description: >-
Most AFM cases are preceded by a short febrile or upper respiratory illness,
typically 1-10 days before the onset of weakness.
phenotype_term:
preferred_term: acute prodromal respiratory tract infection
term:
id: HP:0011947
label: Respiratory tract infection
temporality: ACUTE
evidence:
- reference: PMID:39163469
reference_title: Acute Flaccid Myelitis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "upper respiratory tract infection"
explanation: >-
The clinical summary identifies a preceding upper respiratory infection;
no frequency band is assigned because the available quantitative endpoint
pooled respiratory and gastrointestinal prodromes.
- name: Acute flaccid paralysis
category: Neurologic
phenotype_term:
preferred_term: acute flaccid paralysis
term:
id: HP:0003470
label: Paralysis
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "acute flaccid paralysis"
explanation: >-
Acute flaccid paralysis is part of the core clinical description of AFM.
- name: Acute limb weakness
category: Neurologic
phenotype_term:
preferred_term: acute limb weakness
term:
id: HP:0003690
label: Limb muscle weakness
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "acute-onset flaccid limb weakness"
explanation: >-
The review identifies acute flaccid limb weakness as a defining feature.
- name: Asymmetric limb weakness
category: Neurologic
frequency: FREQUENT
description: >-
Limb weakness is often asymmetric in AFM and helps distinguish AFM from
Guillain-Barre syndrome in children with acute flaccid paralysis.
phenotype_term:
preferred_term: asymmetric limb weakness
term:
id: HP:0003690
label: Limb muscle weakness
evidence:
- reference: PMID:34747551
reference_title: "Acute flaccid myelitis and Guillain-Barré syndrome in children: A comparative study with evaluation of diagnostic criteria."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "asymmetric limb weakness (58% vs. 0%, p < 0.001)"
explanation: >-
Fifty-eight percent of the AFM cohort had asymmetric weakness, supporting
the frequent band and its value against GBS.
- name: Areflexia
category: Neurologic
phenotype_term:
preferred_term: Areflexia
term:
id: HP:0001284
label: Areflexia
evidence:
- reference: PMID:39163469
reference_title: Acute Flaccid Myelitis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "decreased or absent reflexes"
explanation: >-
The StatPearls clinical summary supports decreased or absent reflexes as a
classic AFM finding.
- name: Spinal cord gray matter lesion
category: Neurologic
frequency: VERY_FREQUENT
phenotype_term:
preferred_term: spinal cord gray matter lesion
term:
id: HP:0100561
label: Spinal cord lesion
evidence:
- reference: PMID:26720027
reference_title: "Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Fifty-six patients had T2 hyperintensity of spinal gray matter on magnetic resonance imaging"
explanation: >-
Fifty-six of 59 cases had the MRI abnormality, supporting the
very-frequent band.
- name: CSF pleocytosis
category: Neurologic
frequency: FREQUENT
phenotype_term:
preferred_term: CSF pleocytosis
term:
id: HP:0012229
label: CSF pleocytosis
evidence:
- reference: PMID:26720027
reference_title: "Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "43 patients had cerebrospinal fluid pleocytosis"
explanation: >-
Forty-three of 59 cases had CSF pleocytosis, supporting the frequent band.
- name: Cranial nerve palsy
category: Neurologic
phenotype_term:
preferred_term: Cranial nerve palsy
term:
id: HP:0006824
label: Cranial nerve paralysis
evidence:
- reference: PMID:31014167
reference_title: "Acute Flaccid Myelitis Associated With Enterovirus D68: A Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "with cranial neuropathy"
explanation: >-
The EV-D68-associated AFM review describes cranial neuropathy among common
presenting features.
- name: Facial weakness
category: Neurologic
phenotype_term:
preferred_term: Facial weakness
term:
id: HP:0030319
label: Weakness of facial musculature
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Respiratory, axial, bulbar, facial, and extraocular muscles may also be affected."
explanation: >-
The review lists facial muscle involvement in the broader set of AFM
muscle groups that can be affected.
- name: Bulbar palsy
category: Neurologic
phenotype_term:
preferred_term: Bulbar palsy
term:
id: HP:0001283
label: Bulbar palsy
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Respiratory, axial, bulbar, facial, and extraocular muscles may also be affected."
explanation: >-
The review lists bulbar involvement in the broader set of AFM muscle
groups that can be affected.
- name: Respiratory insufficiency due to muscle weakness
category: Respiratory
frequency: OCCASIONAL
phenotype_term:
preferred_term: Respiratory insufficiency due to muscle weakness
term:
id: HP:0002747
label: Respiratory insufficiency due to muscle weakness
evidence:
- reference: PMID:39657203
reference_title: "Pediatric Patients With Acute Flaccid Myelitis: Long-term Respiratory and Neurologic Outcomes."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Eight patients (21.6%) had respiratory failure during the index hospitalization."
explanation: >-
Eight of 37 children had respiratory failure, directly supporting the
occasional frequency band in this cohort.
imaging_findings:
- name: Longitudinal spinal gray-matter T2 hyperintensity on MRI
modality: MRI
imaging_finding_term:
preferred_term: spinal cord lesion
term:
id: HP:0100561
label: Spinal cord lesion
description: >-
T2 hyperintensity centered in spinal gray matter, often longitudinally
extensive and most conspicuous in the anterior horns, is the defining
radiologic AFM finding. A predominantly gray-matter lesion spanning at least
one spinal segment is part of the confirmed surveillance case definition.
located_in:
preferred_term: ventral horn of spinal cord
term:
id: UBERON:0002257
label: ventral horn of spinal cord
spatial_extent: EXTENSIVE
phenotype_term:
preferred_term: spinal cord gray matter lesion
term:
id: HP:0100561
label: Spinal cord lesion
diagnostic: true
frequency: VERY_FREQUENT
evidence:
- reference: PMID:31409689
reference_title: Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
magnetic resonance imaging evidence of a predominantly gray matter lesion
that spans at least one spinal segment
explanation: The published surveillance definition establishes the diagnostic morphology.
- reference: PMID:26720027
reference_title: "Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Fifty-six patients had T2 hyperintensity of spinal gray matter on magnetic resonance imaging"
explanation: Fifty-six of 59 cases support the very-frequent frequency band.
diagnosis:
- name: MRI-centered AFM evaluation
description: >-
Suspected AFM evaluation centers on urgent neurologic examination and MRI of
the entire spinal cord and brainstem to detect gray-matter lesions. CSF
analysis, respiratory and stool testing, poliovirus exclusion, and early
electrodiagnostic testing help characterize inflammation, seek an infectious
association, and distinguish peripheral neuropathy.
diagnosis_term:
preferred_term: magnetic resonance imaging procedure
term:
id: NCIT:C16809
label: Magnetic Resonance Imaging
results: >-
Longitudinal spinal cord gray-matter lesions, especially anterior horn
involvement, support AFM in the right clinical context.
evidence:
- reference: PMID:26621554
reference_title: Recognition and Management of Acute Flaccid Myelitis in Children.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "spinal gray matter lesions"
explanation: >-
Pediatric case series supports MRI detection of spinal gray matter lesions
as a key recognition feature.
- reference: PMID:33357469
reference_title: "Acute flaccid myelitis: cause, diagnosis, and management."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "clinical, neuroimaging, and cerebrospinal fluid characteristics"
explanation: >-
The Lancet review supports an integrated diagnostic workup rather than a
single confirmatory test.
- name: CSF and respiratory or stool enterovirus testing
description: >-
CSF cell count and protein are supportive, while respiratory and stool
specimens should be collected early for enterovirus typing and poliovirus
exclusion. A negative CSF PCR does not exclude AFM or an enterovirus
association because viral RNA is rarely recovered from CSF.
results: >-
Pleocytosis supports CNS inflammation; enterovirus detection outside CSF can
support an association but does not independently prove viral causation of
the neurologic syndrome.
evidence:
- reference: PMID:31409689
reference_title: Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "An infectious agent is only rarely detected in cerebrospinal fluid (CSF)."
explanation: Rare CSF detection explains why negative CSF PCR cannot exclude AFM.
- reference: PMID:26720027
reference_title: "Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "No pathogens were isolated from the cerebrospinal fluid."
explanation: The 59-case series illustrates the low yield of CSF pathogen testing.
- name: Mimic exclusion
description: >-
AFM diagnosis requires careful exclusion of other causes of acute flaccid
paralysis, especially Guillain-Barre syndrome, spinal cord stroke, acute
transverse myelitis, poliomyelitis, and compressive or structural spinal
cord disease.
notes: >-
Key mimics include Guillain-Barre syndrome, spinal cord infarction,
transverse myelitis, poliomyelitis, and structural spinal cord disease.
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Guillain-Barre syndrome, spinal cord stroke, and transverse myelitis"
explanation: >-
The clinical review explicitly lists these major AFM mimics.
differential_diagnoses:
- name: Guillain-Barre syndrome
disease_term:
preferred_term: Guillain-Barre syndrome
term:
id: MONDO:0016218
label: Guillain-Barre syndrome
description: >-
GBS also causes acute weakness and areflexia, but weakness is usually more
symmetric, sensory deficits are more common, progression to nadir is slower,
CSF protein is higher relative to leukocytes, and spinal gray-matter lesions
favor AFM.
distinguishing_features:
- AFM reached nadir sooner in a pediatric comparison (3 versus 8 days).
- Asymmetric weakness and lack of sensory deficits favored AFM.
- Spinal-cord lesions were found only in AFM in the comparative cohort.
evidence:
- reference: PMID:34747551
reference_title: "Acute flaccid myelitis and Guillain-Barré syndrome in children: A comparative study with evaluation of diagnostic criteria."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
shorter interval between onset of weakness and nadir (3 vs. 8 days, p <
0.001), more often had asymmetric limb weakness (58% vs. 0%, p < 0.001),
and less frequently had sensory deficits (0% vs. 40%, p < 0.001)
explanation: The direct pediatric comparison supplies the principal early distinctions.
- name: Acute transverse myelitis
disease_term:
preferred_term: acute transverse myelitis
term:
id: MONDO:0015342
label: acute transverse myelitis
description: >-
Transverse myelitis can produce acute weakness and a spinal lesion, but a
sensory level, bowel or bladder dysfunction, upper-motor-neuron evolution,
and a lesion not selectively centered in anterior-horn gray matter favor
transverse myelitis over AFM.
distinguishing_features:
- Sensory and autonomic spinal-cord dysfunction are more prominent.
- MRI involvement is not restricted to the anterior-horn gray-matter pattern.
evidence:
- reference: PMID:36996587
reference_title: "Pediatric acute flaccid myelitis: Evaluation of diagnostic criteria and differentiation from other causes of acute flaccid paralysis."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Patients initially classified as probable or possible AFM were most commonly diagnosed with transverse myelitis (16/25)."
explanation: This diagnostic study establishes transverse myelitis as the main probable/possible AFM mimic.
- name: Poliomyelitis
disease_term:
preferred_term: poliomyelitis
term:
id: MONDO:0017373
label: poliomyelitis
description: >-
Poliomyelitis can be clinically and anatomically indistinguishable from AFM.
Travel and vaccination history plus urgent stool testing for poliovirus are
required because a non-polio AFM label must not delay public-health response
to possible poliovirus.
distinguishing_features:
- Poliovirus detection establishes poliomyelitis rather than non-polio AFM.
- Epidemiologic exposure and immunization history change the pretest probability.
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "striking similarities to cases of poliomyelitis"
explanation: The clinical review supports the close phenotypic overlap.
- name: Spinal cord infarction
description: >-
Spinal cord infarction can cause abrupt flaccid weakness and initially mimic
AFM. Hyperacute maximal deficit, a vascular or hypotensive context, restricted
diffusion, and a vascular-territory pattern favor infarction.
distinguishing_features:
- Deficit is often maximal at onset rather than progressing over several days.
- Diffusion restriction and vascular-territory MRI findings favor infarction.
evidence:
- reference: PMID:32143233
reference_title: "Acute Flaccid Myelitis: A Clinical Review."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Guillain-Barre syndrome, spinal cord stroke, and transverse myelitis."
explanation: The AFM clinical review explicitly includes spinal cord stroke among major mimics.
progression:
- phase: Rapid progression to acute nadir
notes: >-
Weakness progresses over hours to days. In a direct pediatric comparison,
AFM reached nadir sooner than GBS, reinforcing the need for prompt MRI,
respiratory monitoring, and specimen collection.
evidence:
- reference: PMID:34747551
reference_title: "Acute flaccid myelitis and Guillain-Barré syndrome in children: A comparative study with evaluation of diagnostic criteria."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "shorter interval between onset of weakness and nadir (3 vs. 8 days, p < 0.001)"
explanation: >-
The comparative cohort places median AFM nadir at three days.
- phase: Chronic motor deficit with partial functional recovery
notes: >-
Persistent focal paralysis is common, although disability and activity of
daily living can continue to improve over years. Motor recovery is generally
less complete than recovery of nonmotor neurologic findings.
evidence:
- reference: PMID:33388543
reference_title: Three-Year Longitudinal Motor Function and Disability Level of Acute Flaccid Myelitis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "AFM has a high rate of persistent motor deficits showing one- to two-limb paralysis."
explanation: >-
Three-year follow-up establishes persistence of focal motor deficits.
- reference: PMID:33388543
reference_title: Three-Year Longitudinal Motor Function and Disability Level of Acute Flaccid Myelitis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Disability level of patients with AFM, however, generally improved at the three-year time point."
explanation: >-
Functional improvement despite residual paralysis gives a more nuanced
prognosis than either full recovery or fixed disability.
- phase: Long-term respiratory morbidity after acute respiratory failure
notes: >-
Children requiring respiratory support during the acute illness have a
higher risk of chronic respiratory support, health-care use, and prolonged
neurologic disability.
evidence:
- reference: PMID:39657203
reference_title: "Pediatric Patients With Acute Flaccid Myelitis: Long-term Respiratory and Neurologic Outcomes."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "Among children with respiratory failure, 6 patients (75%) required follow-up respiratory support."
explanation: >-
Six of eight children with acute respiratory failure required later
respiratory support, defining a high-risk prognostic subgroup.
treatments:
- name: Acute supportive care
description: >-
Acute management is primarily supportive and includes close monitoring for
bulbar and respiratory muscle involvement, intensive-care support when
needed, pain control, prevention of complications, and multidisciplinary
neurologic and infectious-disease evaluation.
treatment_term:
preferred_term: supportive care
term:
id: NCIT:C15747
label: Supportive Care
target_phenotypes:
- preferred_term: Respiratory insufficiency due to muscle weakness
term:
id: HP:0002747
label: Respiratory insufficiency due to muscle weakness
evidence:
- reference: PMID:33357469
reference_title: "Acute flaccid myelitis: cause, diagnosis, and management."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "guide diagnosis, management, and rehabilitation"
explanation: >-
The Lancet review supports management and rehabilitation as central AFM
care domains.
- name: Mechanical ventilatory support
description: >-
Respiratory muscle weakness or bulbar dysfunction can require intubation,
invasive mechanical ventilation, or other airway and respiratory support.
treatment_term:
preferred_term: mechanical ventilation
term:
id: NCIT:C70909
label: Mechanical Ventilation
target_phenotypes:
- preferred_term: Respiratory insufficiency due to muscle weakness
term:
id: HP:0002747
label: Respiratory insufficiency due to muscle weakness
evidence:
- reference: PMID:39163469
reference_title: Acute Flaccid Myelitis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "requires intubation and mechanical ventilation"
explanation: >-
The current clinical summary supports ventilatory support for severe AFM
respiratory insufficiency.
- name: Physical therapy and rehabilitation
description: >-
Long-term care relies on early, intensive, and individualized
rehabilitation, including physical therapy, occupational therapy, bracing,
orthopedic monitoring, and functional support for residual motor deficits.
therapeutic_modality: BEHAVIORAL
treatment_term:
preferred_term: physical therapy
term:
id: NCIT:C15302
label: Physical Therapy
target_phenotypes:
- preferred_term: Limb muscle weakness
term:
id: HP:0003690
label: Limb muscle weakness
evidence:
- reference: PMID:33357469
reference_title: "Acute flaccid myelitis: cause, diagnosis, and management."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "unique long-term rehabilitation needs"
explanation: >-
The Lancet review directly supports rehabilitation as a core AFM
management need.
- name: Transcutaneous spinal cord stimulation with gait training
description: >-
Transcutaneous spinal cord stimulation paired with gait training has early
pediatric case-series evidence for feasibility and walking-function
improvement after AFM-related incomplete spinal cord injury. This is an
investigational rehabilitation adjunct rather than established standard
care.
treatment_term:
preferred_term: spinal cord stimulation
term:
id: NCIT:C21023
label: Spinal Cord Stimulation
target_phenotypes:
- preferred_term: Limb muscle weakness
term:
id: HP:0003690
label: Limb muscle weakness
evidence:
- reference: DOI:10.3390/children11091116
reference_title: Transcutaneous Spinal Cord Stimulation Enables Recovery of Walking in Children with Acute Flaccid Myelitis
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "safe and clinically feasible intervention"
explanation: >-
A four-child case series supports feasibility and possible walking benefit
but remains preliminary evidence.
- name: Reconstructive surgery for persistent paralysis
description: >-
Selected patients with persistent severe upper-extremity paralysis after AFM
may undergo reconstructive procedures such as nerve transfer,
muscle-tendon transfer, or free muscle transfer. Evidence remains
observational and procedure selection depends on residual donor-nerve and
synergistic-muscle function.
therapeutic_modality: SURGERY
treatment_term:
preferred_term: surgical procedure
term:
id: NCIT:C15329
label: Surgical Procedure
target_phenotypes:
- preferred_term: Upper limb muscle weakness
term:
id: HP:0003484
label: Upper limb muscle weakness
evidence:
- reference: DOI:10.2106/JBJS.OA.23.00143
reference_title: Midterm Outcomes of Surgical Reconstruction and Spontaneous Recovery of Upper-Extremity Paralysis Following Acute Flaccid Myelitis
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "nerve transfer, muscle-tendon transfer, or free muscle transfer"
explanation: >-
This retrospective cohort supports reconstructive surgery as a selected
intervention for persistent AFM upper-extremity paralysis.
- name: Immunomodulatory acute therapies
description: >-
Intravenous immunoglobulin, corticosteroids, and plasma exchange have been
used empirically in AFM, especially early in the syndrome when mimics remain
possible. Available clinical evidence does not establish that these
therapies reverse AFM motor neuron injury, so this entry models them as
empiric and uncertain rather than proven disease-modifying treatment.
Preclinical EV-D68 AFM-model data further caution against assuming benefit
from corticosteroids.
treatment_term:
preferred_term: Pharmacotherapy
term:
id: NCIT:C15986
label: Pharmacotherapy
evidence:
- reference: PMID:26621554
reference_title: Recognition and Management of Acute Flaccid Myelitis in Children.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "intravenous immunoglobulin, corticosteroids, or plasma exchange"
explanation: >-
The case series documents real-world use of immune therapies but also
persistent deficits, so it supports exposure rather than proven efficacy.
- reference: PMID:28968718
reference_title: Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "Dexamethasone treatment worsened motor impairment, increased mortality, and increased viral loads."
explanation: >-
Mouse-model evidence specifically cautions that corticosteroid exposure
may worsen EV-D68 paralytic myelitis biology, although it is not direct
human treatment evidence.
clinical_trials:
- name: NCT02144935
phase: NOT_APPLICABLE
status: COMPLETED
description: >-
CAPTURE was an observational pediatric registry and data repository for
transverse myelitis or AFM, using surveys, interviews, and medical-record
review to characterize recovery and inform future clinical trials.
evidence:
- reference: clinicaltrials:NCT02144935
reference_title: "Collaborative Assessment of Pediatric Transverse Myelitis: Understand, Reveal, Educate or CAPTURE Study"
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "transverse myelitis (TM) or acute flaccid myelitis (AFM)"
explanation: >-
ClinicalTrials.gov confirms that CAPTURE enrolled pediatric TM or AFM
patients for registry-based outcomes follow-up.
- name: NCT03499366
phase: NOT_APPLICABLE
status: UNKNOWN
description: >-
European observational follow-up study of pediatric acute flaccid myelitis
associated with EV-D68 infection, designed to assess clinical outcome and
correlations with severity, treatment, and MRI findings.
evidence:
- reference: clinicaltrials:NCT03499366
reference_title: A Clinical Observational Follow-up Study of European Pediatric Cases of Acute Flaccid Myelitis Associated With EV-D68 Infection.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "acute flaccid paresis associated with enterovirus D68 infection"
explanation: >-
ClinicalTrials.gov identifies an EV-D68-associated pediatric AFM follow-up
study.
animal_models:
- species: mouse
background: neonatal mice experimentally infected with EV-D68
category: Viral infection mouse model
description: >-
Neonatal mouse models infected with contemporary EV-D68 outbreak strains
develop paralytic myelitis resembling human AFM, with virus and viral genome
in spinal cord and motor neuron loss in anterior horns corresponding to
paralyzed limbs.
associated_phenotypes:
- Paralytic myelitis
- Motor neuron loss
- Limb paralysis
evidence:
- reference: PMID:28231269
reference_title: A mouse model of paralytic myelitis caused by enterovirus D68.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "four EV-D68 strains from the 2014 outbreak (out of five tested) produced a paralytic disease in mice resembling human AFM."
explanation: >-
This animal-model study supports EV-D68 as capable of producing an
AFM-like paralytic phenotype in neonatal mice.
- reference: PMID:28231269
reference_title: A mouse model of paralytic myelitis caused by enterovirus D68.
supports: SUPPORT
evidence_source: MODEL_ORGANISM
snippet: "infection and loss of motor neurons in the anterior horns of spinal cord segments corresponding to paralyzed limbs."
explanation: >-
The model recapitulates the anterior-horn motor neuron injury central to
human AFM pathophysiology.
experimental_models:
- name: Human iPSC-derived spinal cord organoids infected with EV-D68
description: >-
Two three-dimensional human spinal-cord organoid systems, one enriched for
spinal motor neurons and one containing multiple neuronal and glial
lineages, model productive infection by contemporary EV-D68 strains. They
reproduce neural tropism but not the immune-cell environment or the full
route from respiratory infection to human paralysis.
experimental_model_type: ORGANOID
organism:
preferred_term: human
term:
id: NCBITaxon:9606
label: Homo sapiens
tissue_term:
preferred_term: spinal cord
term:
id: UBERON:0002240
label: spinal cord
cell_types:
- preferred_term: motor neuron
term:
id: CL:0000100
label: motor neuron
- preferred_term: astrocyte
term:
id: CL:0000127
label: astrocyte
- preferred_term: oligodendrocyte precursor cell
term:
id: CL:0002453
label: oligodendrocyte precursor cell
conditions:
- Naive or EV-D68-infected human spinal cord organoids
cell_source: Human induced pluripotent stem cell-derived spinal neural cells
culture_system: Three-dimensional multicellular spinal cord organoids
publication: DOI:10.1128/mbio.01058-23
modeled_mechanisms:
- target: Spinal Neural Cell Tropism and Infection
description: >-
Tests whether historical and contemporary EV-D68 strains productively
infect human spinal neural populations.
evidence:
- reference: DOI:10.1128/mbio.01058-23
reference_title: Contemporary enterovirus-D68 isolates infect human spinal cord organoids
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "productively infected with contemporary strains, but not a historic strain, of EV-D68"
explanation: The organoid infection directly models the curated tropism mechanism.
- target: Spinal Gray Matter Inflammation and Motor Neuron Injury
description: >-
Separates productive viral infection from overt cytopathic injury and
motivates testing secondary immune-mediated damage.
evidence:
- reference: DOI:10.1128/mbio.01058-23
reference_title: Contemporary enterovirus-D68 isolates infect human spinal cord organoids
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "secondary injury from the immune response likely contributes to pathogenesis"
explanation: The model motivates, but does not itself reproduce, secondary immune injury.
findings:
- statement: Contemporary, but not historical, EV-D68 strains productively infect spinal cord organoids.
supporting_text: >-
These hSCOs can be productively infected with contemporary strains, but
not a historic strain, of EV-D68 and produce extracellular virus for at
least 2 weeks without appreciable cytopathic effect.
evidence:
- reference: DOI:10.1128/mbio.01058-23
reference_title: Contemporary enterovirus-D68 isolates infect human spinal cord organoids
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "produce extracellular virus for at least 2 weeks without appreciable cytopathic effect"
explanation: This exact observation supports the finding.
- statement: Cell tropism differs between contemporary EV-D68 strains.
supporting_text: >-
US/IL/14-18952 showed a significant preference for neurons, while
US/MA/18-23089 exhibited higher rates of infection in cycling astrocytes
and OPCs.
evidence:
- reference: DOI:10.3389/fmicb.2025.1698639
reference_title: Strain-specific tropism and transcriptional responses of enterovirus D68 infection in human spinal cord organoids
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "US/IL/14-18952 showed a significant preference for neurons"
explanation: The single-cell study directly supports strain-specific tropism.
evidence:
- reference: DOI:10.1128/mbio.01058-23
reference_title: Contemporary enterovirus-D68 isolates infect human spinal cord organoids
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
produce extracellular virus for at least 2 weeks without appreciable
cytopathic effect
explanation: >-
This establishes sustained productive infection while showing that viral
cytopathy alone does not reproduce the human injury phenotype.
- reference: DOI:10.3389/fmicb.2025.1698639
reference_title: Strain-specific tropism and transcriptional responses of enterovirus D68 infection in human spinal cord organoids
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
US/IL/14-18952 showed a significant preference for neurons, while
US/MA/18-23089 exhibited higher rates of infection in cycling astrocytes
and OPCs.
explanation: Single-cell profiling distinguishes strain-specific target-cell preferences.
datasets:
- accession: DOI:10.3389/fmicb.2025.1698639
title: Single-cell RNA sequencing of EV-D68-infected human spinal cord organoids
description: >-
Single-cell transcriptomic comparison of naive human spinal-cord organoids
and organoids infected with two contemporary EV-D68 strains, resolving
neuronal and glial composition, viral tropism, and host transcriptional
responses.
organism:
preferred_term: human
term:
id: NCBITaxon:9606
label: Homo sapiens
data_type: SINGLE_CELL_RNA_SEQ
conditions:
- Naive human spinal cord organoids
- US/IL/14-18952 EV-D68 infection
- US/MA/18-23089 EV-D68 infection
publication: DOI:10.3389/fmicb.2025.1698639
findings:
- statement: The two tested EV-D68 strains showed distinct cell tropism and host responses.
supporting_text: >-
Upon infection with 2 EV-D68 strains, US/IL/14-18952 (a B2 strain) and
US/MA/18-23089 (a B3 strain), we observed distinct viral tropism and host
transcriptional responses.
evidence:
- reference: DOI:10.3389/fmicb.2025.1698639
reference_title: Strain-specific tropism and transcriptional responses of enterovirus D68 infection in human spinal cord organoids
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "we observed distinct viral tropism and host transcriptional responses"
explanation: The source directly states the dataset-level finding.
evidence:
- reference: DOI:10.3389/fmicb.2025.1698639
reference_title: Strain-specific tropism and transcriptional responses of enterovirus D68 infection in human spinal cord organoids
supports: SUPPORT
evidence_source: IN_VITRO
snippet: "we profiled naive and EV-D68-infected human spinal cord organoids (hSCOs) derived from induced pluripotent stem cells (iPSCs) using single-cell RNA sequencing (scRNA-seq)"
explanation: The publication directly describes the dataset design and assay.
discussions:
- discussion_id: afm_ev_d68_human_causation_boundary
prompt: >-
What proportion of human AFM is directly caused by EV-D68 neuroinvasion,
and which tests can establish that cause in an individual patient?
kind: KNOWLEDGE_GAP
status: OPEN
attaches_to:
- infectious_agent#Enterovirus D68
- pathophysiology#Non-polio Enterovirus Respiratory Infection
rationale: >-
Outbreak timing, respiratory detections, CSF antibodies, animal causation,
and human-organoid infection form a coherent causal case. However, viral RNA
is rarely detected in human CSF, case-control estimates are heterogeneous,
and AFM is a syndrome with other infectious and noninfectious mimics. The
graph therefore treats EV-D68 neuroinvasion as the canonical model for
epidemic disease without assigning it to every case.
evidence:
- reference: PMID:42066114
reference_title: "Enterovirus D68 and Acute Neurologic Outcomes: A Systematic Review and Meta-Analysis (2010-2025)."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: >-
Across 98 studies, the pooled odds ratio (OR) was 1.39 (95% CI 1.14-1.69),
with high heterogeneity (I2 = 98.9%; prediction interval 0.24-8.15).
explanation: The high heterogeneity quantifies uncertainty in human association estimates.
- reference: PMID:31409689
reference_title: Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "supports the plausibility of a link between EV infection and AFM that warrants further investigation"
explanation: The CSF-antibody study explicitly frames its evidence as plausibility, not proof.
posed_date: "2026-07-20T00:00:00Z"
- discussion_id: afm_respiratory_wave_paralysis_mismatch
prompt: >-
Why do large EV-D68 respiratory waves not consistently produce parallel AFM
peaks, and what host or viral determinants govern the rare paralytic outcome?
kind: KNOWLEDGE_GAP
status: OPEN
attaches_to:
- epidemiology#United States surveillance since the 2018 peak
- environmental#EV-D68 respiratory circulation and wastewater seasonality
rationale: >-
AFM counts remained low during the 2022 US EV-D68 circulation increase.
Prospective linked respiratory, wastewater, genomic, host-immunologic, and
neurologic surveillance is needed to distinguish viral genotype, prior
immunity, ascertainment, and host susceptibility effects.
evidence:
- reference: PMID:38300829
reference_title: "Surveillance for Acute Flaccid Myelitis - United States, 2018-2022."
supports: SUPPORT
evidence_source: HUMAN_CLINICAL
snippet: "It is unclear why EV-D68 circulation in 2022 was not associated with an increase in AFM cases"
explanation: The national surveillance report states the mismatch directly.
posed_date: "2026-07-20T00:00:00Z"
- discussion_id: afm_organoid_mouse_translation_limit
prompt: >-
Which immune and developmental features must be added to organoid and mouse
systems to reproduce human AFM motor-neuron loss and recovery?
kind: HUMAN_MODEL_MISMATCH
status: OPEN
attaches_to:
- experimental_models#Human iPSC-derived spinal cord organoids infected with EV-D68
- animal_models#mouse
rationale: >-
Organoids show prolonged productive infection without appreciable cytopathy
and lack a complete immune compartment. Mice are not native EV-D68 hosts and
commonly require neonatal or modified conditions. These systems prove
mechanistic capabilities but cannot determine the human balance between
direct infection and immune-mediated injury.
evidence:
- reference: DOI:10.1128/mbio.01058-23
reference_title: Contemporary enterovirus-D68 isolates infect human spinal cord organoids
supports: SUPPORT
evidence_source: IN_VITRO
snippet: >-
Mice are not native hosts for EV-D68, and thus, existing mouse models use
immunosuppressed or neonatal mice, mouse-adapted viruses, or intracranial
inoculations.
explanation: The organoid paper directly states key limitations of animal translation.
posed_date: "2026-07-20T00:00:00Z"
review_notes: >-
Comprehensive 2026 review corrected AFM identity and scope, replaced
virus-associated pseudo-subtypes with infectious-agent relationships, and
separated human association from experimental causation. The pathograph now
connects infection, receptor-mediated entry, neural tropism, gray-matter and
motor-neuron injury, lower-motor-neuron dysfunction, and every curated
phenotype with typed, cited edges. MRI, CSF/virologic diagnosis, major
differentials, long-term prognosis, supportive/rehabilitative/surgical care,
experimental models, and surveillance uncertainty were audited.
references:
- reference: ORPHA:623801
title: Acute flaccid myelitis
- reference: PMID:26621554
title: Recognition and Management of Acute Flaccid Myelitis in Children.
- reference: PMID:27422805
title: "Acute flaccid myelitis: A clinical review of US cases 2012-2015."
- reference: PMID:31014167
title: "Acute Flaccid Myelitis Associated With Enterovirus D68: A Review."
- reference: PMID:31409689
title: Antibodies to Enteroviruses in Cerebrospinal Fluid of Patients with Acute Flaccid Myelitis.
- reference: PMID:32143233
title: "Acute Flaccid Myelitis: A Clinical Review."
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
- reference: PMID:33357469
title: "Acute flaccid myelitis: cause, diagnosis, and management."
- reference: PMID:36268734
title: "Epidemiology of acute flaccid myelitis in children in the Netherlands, 2014 to 2019."
- reference: PMID:39163469
title: Acute Flaccid Myelitis.
- reference: PMID:40132641
title: MFSD6 is an entry receptor for enterovirus D68.
- reference: clinicaltrials:NCT02144935
title: "Collaborative Assessment of Pediatric Transverse Myelitis: Understand, Reveal, Educate or CAPTURE Study"
- reference: clinicaltrials:NCT03499366
title: A Clinical Observational Follow-up Study of European Pediatric Cases of Acute Flaccid Myelitis Associated With EV-D68 Infection.
- reference: DOI:10.15585/mmwr.mm7304a1
title: "Surveillance for Acute Flaccid Myelitis - United States, 2018-2022"
found_in:
- Acute_Flaccid_Myelitis-deep-research-falcon.md
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
- reference: PMID:38300829
title: Surveillance for Acute Flaccid Myelitis - United States, 2018-2022.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: DOI:10.15585/mmwr.mm6931e3
title: "<i>Vital Signs:</i> Clinical Characteristics of Patients with Confirmed Acute Flaccid Myelitis, United States, 2018"
found_in:
- Acute_Flaccid_Myelitis-deep-research-falcon.md
- reference: DOI:10.3201/eid3003.231223
title: Multimodal Surveillance Model for Enterovirus D68 Respiratory Disease and Acute Flaccid Myelitis among Children in Colorado, USA, 2022
found_in:
- Acute_Flaccid_Myelitis-deep-research-falcon.md
- reference: DOI:10.1128/mbio.01058-23
title: Contemporary enterovirus-D68 isolates infect human spinal cord organoids
found_in:
- Acute_Flaccid_Myelitis-deep-research-falcon.md
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
- reference: PMID:37535397
title: Contemporary enterovirus-D68 isolates infect human spinal cord organoids.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: DOI:10.1159/000535316
title: A first case of acute flaccid myelitis related to enterovirus D-68 in Belgium
found_in:
- Acute_Flaccid_Myelitis-deep-research-falcon.md
- reference: DOI:10.2106/JBJS.OA.23.00143
title: Midterm Outcomes of Surgical Reconstruction and Spontaneous Recovery of Upper-Extremity Paralysis Following Acute Flaccid Myelitis
found_in:
- Acute_Flaccid_Myelitis-deep-research-falcon.md
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
- reference: PMID:38774108
title: Midterm Outcomes of Surgical Reconstruction and Spontaneous Recovery of Upper-Extremity Paralysis Following Acute Flaccid Myelitis.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: DOI:10.1016/j.pmr.2021.02.004
title: Acute Flaccid Myelitis
found_in:
- Acute_Flaccid_Myelitis-deep-research-falcon.md
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
- reference: PMID:37465770
title: Acute Flaccid Myelitis.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: DOI:10.3390/children11091116
title: Transcutaneous Spinal Cord Stimulation Enables Recovery of Walking in Children with Acute Flaccid Myelitis
found_in:
- Acute_Flaccid_Myelitis-deep-research-falcon.md
- reference: DOI:10.1177/0883073820975230
title: "Acute Flaccid Myelitis: A Multidisciplinary Protocol to Optimize Diagnosis and Evaluation"
found_in:
- Acute_Flaccid_Myelitis-deep-research-falcon.md
- reference: DOI:10.3389/fmicb.2025.1698639
title: Strain-specific tropism and transcriptional responses of enterovirus D68 infection in human spinal cord organoids
found_in:
- Acute_Flaccid_Myelitis-deep-research-falcon.md
- reference: PMID:26720027
title: Acute Flaccid Myelitis of Unknown Etiology in California, 2012-2015.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:28231269
title: A mouse model of paralytic myelitis caused by enterovirus D68.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:28424289
title: Disruption of MDA5-Mediated Innate Immune Responses by the 3C Proteins of Coxsackievirus A16, Coxsackievirus A6, and Enterovirus D68.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:28615421
title: Outcomes of Colorado children with acute flaccid myelitis at 1 year.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:28968718
title: Evaluating Treatment Efficacy in a Mouse Model of Enterovirus D68-Associated Paralytic Myelitis.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:29385753
title: A Mouse Model of Enterovirus D68 Infection for Assessment of the Efficacy of Inactivated Vaccine.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:30169722
title: Acute flaccid myelitis-Clustering of polio-like illness in the tertiary care centre in Southern India.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:30503887
title: A neonatal mouse model of Enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:30530701
title: Molecular basis for the acid-initiated uncoating of human enterovirus D68.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:30575890
title: Clinical, Radiologic, and Prognostic Features of Myelitis Associated With Myelin Oligodendrocyte Glycoprotein Autoantibody.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:30985511
title: 'Incidence, Risk Factors and Outcomes Among Children With Acute Flaccid Myelitis: A Population-based Cohort Study in a California Health Network Between 2011 and 2016.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:31338675
title: 'Acute flaccid myelitis and enterovirus D68: lessons from the past and present.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:32178602
title: Acute flaccid myelitis - has it gone unrecognised in Australian children?
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:32192819
title: Acute Flaccid Myelitis Among Hospitalized Children in Texas, 2016.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:32492201
title: 'Seroepidemiology of enterovirus D68 in a healthy population in Beijing, China, between 2012 and 2017: A retrospective study.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:32677590
title: 'Acute Flaccid Myelitis: A Single Pediatric Center Experience From 2014 to 2019.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:32784424
title: Mapping Attenuation Determinants in Enterovirus-D68.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:32836175
title: Cytokine biomarkers associated with clinical cases of acute flaccid myelitis.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:32951650
title: 'The Utilization of Nerve Transfer for Reestablishing Shoulder Function in the Setting of Acute Flaccid Myelitis: A Single-Institution Review.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:33016189
title: Recommendations for Therapy following Nerve Transfer for Children with Acute Flaccid Myelitis.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:33218883
title: 'Acute flaccid myelitis outbreak through 2016-2018: A multicenter experience from Turkey.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:33388543
title: Three-Year Longitudinal Motor Function and Disability Level of Acute Flaccid Myelitis.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:34170466
title: Ectopic Expression of TRIM25 Restores RIG-I Expression and IFN Production Reduced by Multiple Enteroviruses 3C(pro).
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:34196272
title: Respiratory and intestinal epithelial cells exhibit differential susceptibility and innate immune responses to contemporary EV-D68 isolates.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:34735423
title: National Surveillance for Acute Flaccid Myelitis - United States, 2018-2020.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:34747551
title: 'Acute flaccid myelitis and Guillain-Barré syndrome in children: A comparative study with evaluation of diagnostic criteria.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:36996587
title: 'Pediatric acute flaccid myelitis: Evaluation of diagnostic criteria and differentiation from other causes of acute flaccid paralysis.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:37804367
title: Insights into the molecular evolution of enterovirus D68.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:37981447
title: 'Nerve Transfer Surgery in Acute Flaccid Myelitis: Prognostic Factors, Long-Term Outcomes, Comparison With Natural History.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:38240591
title: Enterovirus D68 3C protease antagonizes type I interferon signaling by cleaving signal transducer and activator of transcription 1.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:38405019
title: 'A First Case of Acute Flaccid Myelitis Related to Enterovirus D68 in Belgium: Case Report.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:38547499
title: Epidemiological and Clinical Insights into the Enterovirus D68 Upsurge in Europe 2021-2022 and Emergence of Novel B3-Derived Lineages, ENPEN Multicentre Study.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:38815052
title: 'Acute Flaccid Myelitis: Mid-Term Clinical Course of Knee Extension Paralysis and Outcomes of Nerve Transfer.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:38869283
title: VP1 is the primary determinant of neuropathogenesis in a mouse model of enterovirus D68 acute flaccid myelitis.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:39110777
title: A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical models.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:39246649
title: Enterovirus-D68 - A Reemerging Non-Polio Enterovirus that Causes Severe Respiratory and Neurological Disease in Children.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:39332429
title: Global age-stratified seroprevalence of enterovirus D68: a systematic literature review.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:39459875
title: STING Orchestrates EV-D68 Replication and Immunometabolism within Viral-Induced Replication Organelles.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:39657203
title: 'Pediatric Patients With Acute Flaccid Myelitis: Long-term Respiratory and Neurologic Outcomes.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:39933731
title: 'Phrenic Nerve Reconstruction in Pediatric Diaphragm Paralysis: Outcomes and Techniques.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:40042308
title: The structural protein VP3 of enterovirus D68 interacts with MAVS to inhibit the NF-κB signaling pathway.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:40431685
title: Return of the Biennial Circulation of Enterovirus D68 in Colorado Children in 2024 Following the Large 2022 Outbreak.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:40444374
title: 'Acute flaccid myelitis in Europe between 2016 and 2023: indicating the need for better registration.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:40492725
title: Enhanced genomic surveillance of enteroviruses reveals a surge in enterovirus D68 cases, the Johns Hopkins health system, Maryland, 2024.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:40593720
title: A rationally designed 2C inhibitor prevents enterovirus D68-infected mice from developing paralysis.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:40622703
title: 'West Nile Virus: A Review.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:40661021
title: '[Genomic characterization of a case of enterovirus D68 infection in a child from Tongzhou District, Beijing City].'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:40701343
title: ARRDC3 promotes lysosome-mediated YAP degradation to inhibit enterovirus replication.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41138534
title: 'Evolving Features of Acute Flaccid Myelitis After COVID-19: A Four-Case Series.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41175053
title: 'Enterovirus D68: A Novel Inhibitor Reveals Underlying Molecular Mechanisms of Viral Entry and Uncoating.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41205525
title: Matrine activates high xenophagy to inhibit enterovirus replication.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41210583
title: mRNA vaccine expressing enterovirus D68 virus-like particles induces potent neutralizing antibodies and protects against infection.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41251130
title: Efficacy and Safety of Plasmapheresis in Children With Acute Transverse or Flaccid Myelitis, and Guillain-Barré Syndrome.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41305500
title: 'Spinal Cord Injury in Enterovirus D68 Infection: Mechanisms and Pathophysiology in a Mouse Model.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41352537
title: Ubiquitin-specific protease 5 promotes EV-A71 replication by de-ubiquitinating MAVS and IRF3.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41410465
title: 'Environmental surveillance reveals enterovirus diversity in Jinan, China: detection of types D68, A71, A76, B88, A90, and C99.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41467840
title: 'Enterovirus D68 receptor usage: from static attachment to dynamic entry.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41483695
title: 'Designing of a multi-epitope vaccine targeting enterovirus D68: An integrated immunoinformatic and reverse vaccinology approach.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41485562
title: An orally available peptidomimetic with broad-spectrum antiviral activity targeting the enterovirus 2C helicase.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41600837
title: 'Enterovirus D68 Sequence Variations and Pathogenicity: A Review.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41621223
title: New fluoxetine analogues as anti-enterovirus agents targeting 2C protein.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41650963
title: Mechanosensation promotes broad-spectrum antiviral defense through membrane remodeling.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41667472
title: Rational design and in vivo validation of capsid inhibitors for enterovirus D68.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41853773
title: 'Enterovirus D68 in United States wastewater: a longitudinal surveillance study integrating climatic, demographic, and clinical data.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41868141
title: 'Respiratory enterovirus D68: virology, clinical surveillance, host-pathogen interactions, and therapeutic prospects.'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41964219
title: An RNA-to-RNA pipeline for rapid antiviral antibody development.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:41986256
title: Circulation Patterns, Genetic Diversity, and Public Health Implications of Enterovirus D68, Europe, 2014-2024.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:42018625
title: Enterovirus-induced cleavage of Mitofusin 2 generates mitophagosomes for enveloped virion release.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:42037410
title: EV-D68 exploits clathrin-mediated endocytosis and compensatory macropinocytosis for cellular entry.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:42037414
title: Enterovirus D68 B3 clade strains are efficiently recovered from cDNA infectious clones in 293T cells and infect human spinal cord organoids.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:42063851
title: Rational Design of Capsid Protein VP1 Degraders to Overcome Pleconaril Resistance in Inhibiting Enterovirus D68.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:42066114
title: 'Enterovirus D68 and Acute Neurologic Outcomes: A Systematic Review and Meta-Analysis (2010-2025).'
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
- reference: PMID:42086005
title: Propagation and immunological characterization of three enterovirus D68 strains using serum-free HEK293A suspension cell culture.
found_in:
- Acute_Flaccid_Myelitis-deep-research-openscientist.md
findings: []
Target disease: Acute flaccid myelitis (AFM)
Summary (current understanding): AFM is a rare, severe neurologic syndrome (often pediatric) characterized by acute flaccid limb weakness with spinal cord gray-matter–predominant lesions on MRI, clinically resembling poliomyelitis. In the United States, AFM incidence showed large peaks in 2014/2016/2018 and remained lower in 2019–2022, despite renewed EV-D68 circulation in 2022 without a commensurate AFM surge, emphasizing unresolved determinants of neuroinvasion and paralytic risk. (whitehouse2024surveillanceforacute pages 1-2, kidd2020vitalsignsclinical pages 1-2, messacar2024multimodalsurveillancemodel pages 3-5)
CDC surveillance definitions used in recent U.S. reports define confirmed AFM as acute flaccid limb weakness with MRI demonstrating a spinal cord lesion largely restricted to gray matter spanning ≥1 vertebral segment. (whitehouse2024surveillanceforacute pages 1-2, kidd2020vitalsignsclinical pages 1-2)
A recent European case report restates the CDC framing as “an acute-onset flaccid weakness of one or more limbs” with MRI evidence of gray-matter involvement and no clear alternative diagnosis. (rodesch2024afirstcase pages 1-3)
This report integrates both: * Aggregated public-health surveillance/clinical series (CDC MMWR surveillance; Colorado multimodal surveillance; surgical cohort; rehabilitation case series). (whitehouse2024surveillanceforacute pages 1-2, messacar2024multimodalsurveillancemodel pages 3-5, doi2024midtermoutcomesof pages 1-2, neighbors2024transcutaneousspinalcord pages 5-8) * Individual patient-level case report (Belgium EV-D68-associated AFM). (rodesch2024afirstcase pages 1-3)
Infectious association (dominant current model): AFM is strongly associated with non-polio enteroviruses, particularly enterovirus D68 (EV-D68), based on epidemiologic correlation with outbreak years and frequent detection in non-sterile sites (especially respiratory specimens), while pathogen detection in CSF is uncommon. (murphy2021acuteflaccidmyelitis pages 1-2, kidd2020vitalsignsclinical pages 1-2, whitehouse2024surveillanceforacute pages 1-2)
CDC surveillance indicates that AFM peaks (2014/2016/2018) were linked to EV-D68 circulation, while post-2018 counts remained low; reasons remain uncertain. (whitehouse2024surveillanceforacute pages 1-2)
Multi-pathogen reality: Non–EV-D68 enteroviruses have also been identified in confirmed AFM patients (e.g., EV-A71 and other enteroviruses/echoviruses/coxsackie types), and coinfections can occur. (whitehouse2024surveillanceforacute pages 5-6, whitehouse2024surveillanceforacute pages 6-7)
No validated genetic or environmental protective factors were identified in the retrieved evidence set.
No specific, reproducible gene–environment interaction evidence was identified in the retrieved evidence set.
Acute limb weakness/paralysis is the defining clinical phenotype. CDC describes AFM as “characterized by the acute onset of limb weakness or paralysis.” (kidd2020vitalsignsclinical pages 1-2)
Distribution of weakness varies by outbreak year: In the U.S. 2018 peak year, upper limb involvement was common (84%), while later years showed relatively more lower limb involvement and lower rates of classic peak-year features. (whitehouse2024surveillanceforacute pages 4-5, whitehouse2024surveillanceforacute pages 1-2)
In 2018 confirmed U.S. cases, common findings included: * Gait difficulty: 52% * Neck or back pain: 47% * Fever at evaluation: 35% * Limb pain: 34% (kidd2020vitalsignsclinical pages 1-2)
CSF pleocytosis is common in peak-year AFM, with year-to-year variation; CDC surveillance reports CSF pleocytosis of 87% in 2018 (183/210) versus 42–49% in 2019–2021 and 68% in 2022 (28/41). (whitehouse2024surveillanceforacute pages 4-5)
AFM is associated with high morbidity and incomplete neurologic recovery, with long-term disability common in clinical reviews and cohort summaries. (murphy2021acuteflaccidmyelitis pages 1-2, vawterlee2021acuteflaccidmyelitis pages 2-3)
The retrieved evidence supports, at minimum: * Acute flaccid paralysis / acute limb weakness (HP:0002015 or conceptually similar) * Gait disturbance (HP:0001288) * Neck pain / back pain (HP:0000467 / HP:0003418) * Respiratory failure / need for mechanical ventilation (HP:0002878) * CSF pleocytosis (HP:0002180)
(Note: HPO identifiers are provided as common standard mappings; confirm exact HPO IDs/labels in the current HPO release before database ingestion.)
AFM is not established as a monogenic disorder in the retrieved evidence set; the dominant evidence supports an infectious-triggered neuroinflammatory/anterior horn cell injury syndrome rather than a single-gene etiology. (murphy2021acuteflaccidmyelitis pages 1-2)
No specific host genetic modifiers were identified in the retrieved evidence set.
No AFM-specific epigenetic or chromosomal-abnormality evidence was identified in the retrieved evidence set.
Enteroviruses, particularly EV-D68, are the best-supported associated infectious agents across surveillance and mechanistic modeling. (whitehouse2024surveillanceforacute pages 1-2, kidd2020vitalsignsclinical pages 1-2, aguglia2023contemporaryenterovirusd68isolates pages 1-2)
No toxin/radiation/pollution or lifestyle risk factor evidence was identified in the retrieved evidence set.
1) Preceding viral illness (often respiratory/febrile) occurs days before neurologic onset in many peak-year cases. (kidd2020vitalsignsclinical pages 1-2) 2) Neurotropic infection and/or immune-mediated injury targets spinal cord gray matter (anterior horn/motor neuron regions), producing the MRI signature and motor deficits. (whitehouse2024surveillanceforacute pages 1-2, aguglia2023contemporaryenterovirusd68isolates pages 1-2) 3) Secondary immune-mediated injury is likely important: Human spinal cord organoid data show sustained EV-D68 infection with limited cytopathic effects, implying that infection alone may not explain neuronal loss in vivo.
Aguglia et al. (mBio, 2023-08) emphasize the need for human CNS models because “humans are the only natural hosts for enterovirus infections” and enteroviruses “do not routinely infect other animal species.” (aguglia2023contemporaryenterovirusd68isolates pages 1-2, aguglia2023contemporaryenterovirusd68isolates pages 5-8)
Key findings from the organoid model: * Strain specificity: Contemporary (post-2014) EV-D68 isolates infect spinal cord organoids, whereas a historic strain (Fermon) does not productively infect. (aguglia2023contemporaryenterovirusd68isolates pages 2-5, aguglia2023contemporaryenterovirusd68isolates pages 5-8) * Persistence without marked lysis: Infected organoids “produce extracellular virus for at least 2 weeks without appreciable cytopathic effect” and maintain morphology, with less apoptosis than a comparator enterovirus (echovirus 11). (aguglia2023contemporaryenterovirusd68isolates pages 1-2, aguglia2023contemporaryenterovirusd68isolates pages 8-10) * Immune contribution hypothesis: The authors note that in vitro models lack migratory innate/adaptive immune cells and that this limitation may allow persistence without the injury patterns seen in vivo, supporting a role for immune-mediated secondary damage in AFM. (aguglia2023contemporaryenterovirusd68isolates pages 8-10, aguglia2023contemporaryenterovirusd68isolates pages 10-12)
Rehabilitation literature indicates recovery is often incomplete; functional gains are most robust in the first year but can continue to ~18 months, with persistent proximal weakness/atrophy common. (ide2021acuteflaccidmyelitis. pages 11-13)
United States (CDC surveillance): * Confirmed AFM cases: 238 (2018); 47 (2019); 33 (2020); 28 (2021); 47 (2022). (whitehouse2024surveillanceforacute pages 1-2)
U.S. 2018 clinical severity: * 98% hospitalized, 54% ICU, 23% required intubation/mechanical ventilation. (kidd2020vitalsignsclinical pages 1-2)
Colorado 2022 (EV-D68 outbreak monitoring + AFM burden): * Among 529 EV/RV-positive respiratory specimens tested, 121 (22.9%) were EV-D68-positive, peaking at 78.6% weekly positivity in late August 2022. (messacar2024multimodalsurveillancemodel pages 3-5) * AFM remained uncommon during this EV-D68 respiratory outbreak (Colorado CDC-classified suspected AFM cases in 2022: 4, versus 17 in 2018). (messacar2024multimodalsurveillancemodel pages 5-7)
Not available from the retrieved evidence set.
Rehabilitation review describes a pattern consistent with motor neuronopathy/neuropathy with relative preservation of sensory conduction in most cases. (ide2021acuteflaccidmyelitis. pages 11-13)
A complete differential is not enumerated in the retrieved evidence set; however, case and protocol literature emphasizes the need for prompt workup to distinguish AFM from other causes of acute flaccid paralysis. (rodesch2024afirstcase pages 1-3, vawterlee2021acuteflaccidmyelitis pages 2-3)
Across U.S. surveillance summaries (2018–2022), severe disease was frequent: ICU admission 54%, respiratory support 27%, mechanical ventilation 23%. (whitehouse2024surveillanceforacute pages 5-6)
AFM frequently results in incomplete recovery and long-term sequelae (residual weakness, atrophy, and other neurological/musculoskeletal impacts), as summarized in a major clinical review. (murphy2021acuteflaccidmyelitis pages 1-2)
Case-level prognosis can be poor: the Belgium EV-D68-associated case had persistent proximal arm paresis with shoulder atrophy years later (as summarized in the report excerpt), and authors emphasize poor functional prognosis. (rodesch2024afirstcase pages 3-5)
In a surgical referral cohort, “none of the patients with M0 shoulder abduction at the 6-month evaluation recovered M1 or better”, supporting the use of 6-month post-onset strength as a decision point for surgical reconstruction consideration. (doi2024midtermoutcomesof pages 12-13, doi2024midtermoutcomesof pages 11-12)
CDC surveillance documents real-world use (not efficacy) of: * Steroids alone: 23% * IVIG alone: 23% * Steroids + IVIG: 34% * Plasma exchange (PLEX): 13% (whitehouse2024surveillanceforacute pages 5-6)
Case literature emphasizes absence of evidence-based guidelines and that management is largely supportive, with controversial corticosteroid use and variable IVIG response. (rodesch2024afirstcase pages 3-5)
Suggested MAXO terms (candidates): intravenous immunoglobulin therapy; therapeutic plasma exchange; systemic corticosteroid therapy; supportive respiratory care.
Comprehensive rehabilitation is consistently emphasized as central to functional improvement and quality of life, even without proven disease-modifying therapy. (murphy2021acuteflaccidmyelitis pages 1-2, ide2021acuteflaccidmyelitis. pages 11-13)
2024 development—neuromodulation-assisted gait rehab: A 4-child case series used transcutaneous spinal cord stimulation (TSS) paired with intensive gait training (22 sessions over 5–8 weeks). Feasibility/safety: 98.48% session completion and no significant adverse events; walking endurance improved (6MWT increased by +98.3 m, +68 m, +9.4 m, +49.4 m; 3/4 exceeded MCID). (neighbors2024transcutaneousspinalcord pages 5-8, neighbors2024transcutaneousspinalcord pages 1-2)
Suggested MAXO terms (candidates): physical therapy; gait training; transcutaneous spinal cord stimulation; body-weight–supported treadmill training.
A 2024 cohort study reports nerve transfers, muscle/tendon transfers, and free muscle transfers for persistent deficits; elbow and hand reconstructions showed more consistent outcomes than shoulder reconstructions. (doi2024midtermoutcomesof pages 1-2)
Suggested MAXO terms (candidates): nerve transfer surgery; tendon transfer; free functional muscle transfer; orthopedic reconstruction.
NCT03499366 (ClinicalTrials.gov; first posted 2018-04-17; last update posted 2018-05-11): European pediatric AFM-EV-D68 follow-up study targeting ~40 participants with EV-D68 PCR positivity and MRI-confirmed myelitis, assessing functional outcomes including Hammersmith Functional Motor Scale at 1–3 years and secondary outcomes including ventilator/ICU days and quality of life. (NCT03499366 chunk 1)
No licensed EV-D68 vaccine or AFM-specific preventive therapy is supported in the retrieved evidence set; prevention is currently focused on public health surveillance/early warning and infection control during enterovirus circulation periods. (rodesch2024afirstcase pages 3-5, messacar2024multimodalsurveillancemodel pages 3-5)
A 2024 Colorado program illustrates multimodal surveillance (syndromic ED asthma visits, EV-D68 RT-PCR confirmation, wastewater testing) enabling real-time preparedness actions including provider outreach and surge planning. (messacar2024multimodalsurveillancemodel pages 7-8, messacar2024multimodalsurveillancemodel pages 3-5)
No naturally occurring non-human AFM equivalent was identified in the retrieved evidence set.
Human spinal cord organoids provide a multicellular CNS model for EV-D68 neurotropism; contemporary EV-D68 strains infect and persist with modest cytopathic effect, supporting investigation of immune-mediated injury mechanisms and antiviral testing. (aguglia2023contemporaryenterovirusd68isolates pages 1-2, aguglia2023contemporaryenterovirusd68isolates pages 8-10)
The organoid paper notes limitations of mouse models (often requiring neonatal or immunosuppressed mice, intracranial inoculation, or mouse-adapted viruses), reinforcing why complementary human models are needed. (aguglia2023contemporaryenterovirusd68isolates pages 1-2)
| Topic/Section | Key finding (with key numbers) | Population/Setting | Year | Source (first author, journal) | PMID if available | URL |
|---|---|---|---|---|---|---|
| Surveillance / epidemiology | U.S. confirmed AFM cases: 238 in 2018; then 47 (2019), 33 (2020), 28 (2021), 47 (2022). Confirmed AFM requires acute flaccid limb weakness plus MRI spinal cord lesion largely restricted to gray matter spanning ≥1 vertebral segment. 2018 cases were 94% aged <18 years; median age 5.3 years. ICU admission 54%, respiratory support 27%, mechanical ventilation 23%. EV-D68 detected in 37 cases in 2018; lower in later years. (whitehouse2024surveillanceforacute pages 1-2, whitehouse2024surveillanceforacute pages 5-6, whitehouse2024surveillanceforacute pages 4-5) | United States national AFM surveillance, 2018–2022 | 2024 | Whitehouse, MMWR | https://www.cdc.gov/mmwr/volumes/73/ss/ss7304a1.htm | |
| Clinical characteristics | Among 238 confirmed AFM patients in 2018, median age was 5.3 years; 86% had onset during Aug–Nov; 92% had prodromal fever/respiratory illness beginning median 6 days before weakness; common findings: gait difficulty 52%, neck/back pain 47%, limb pain 34%; 98% hospitalized, 54% ICU, 23% intubated/mechanically ventilated. (kidd2020vitalsignsclinical pages 1-2) | United States confirmed AFM patients during 2018 peak year | 2020 | Kidd, MMWR | https://doi.org/10.15585/mmwr.mm6931e3 | |
| Recent surveillance development | Multimodal Colorado EV-D68/AFM surveillance combined syndromic, clinical PCR, and wastewater data. From Jun 15–Nov 3, 2022, 529 EV/RV-positive respiratory specimens were tested and 121/529 (22.9%) were EV-D68-positive; peak weekly positivity 78.6% in late Aug 2022. Wastewater detection preceded the syndromic alarm by ~1 month/1–2 weeks depending on analytic layer. Colorado had 4 suspected AFM cases in 2022 versus 17 in 2018. (messacar2024multimodalsurveillancemodel pages 5-7, messacar2024multimodalsurveillancemodel pages 3-5, messacar2024multimodalsurveillancemodel pages 7-8) | Colorado, USA pediatric hospital/public-health surveillance during 2022 EV-D68 outbreak | 2024 | Messacar, Emerging Infectious Diseases | https://doi.org/10.3201/eid3003.231223 | |
| Etiology / overall review | AFM is strongly associated with non-polio enteroviruses, especially EV-D68; direct virus detection in CSF is uncommon, but epidemiology, animal models, and CSF antibody studies support causality. Long-term recovery is often incomplete with residual weakness, atrophy, and neurologic/musculoskeletal sequelae; rehabilitation and selected nerve-transfer surgery may improve function. (murphy2021acuteflaccidmyelitis pages 1-2) | International review of human clinical, laboratory, and model-organism evidence | 2021 | Murphy, The Lancet | https://doi.org/10.1016/S0140-6736(20)32723-9 | |
| Rehabilitation / outcomes | AFM rehab review notes electrodiagnostics usually show motor neuronopathy/neuropathy with preserved sensory conduction. Recovery is often poor; some series reported full recovery in only 10% or 41%. Greatest recovery generally occurs within 12 months, but gains may continue to 18 months. Supportive multidisciplinary rehab, ABRT, ventilatory management, diaphragmatic pacing, and nerve transfer surgery are discussed. (ide2021acuteflaccidmyelitis. pages 11-13) | Rehabilitation literature and AFM cohorts, largely pediatric | 2021 | Ide, PM&R Clinics of North America | https://doi.org/10.1016/j.pmr.2021.02.004 | |
| Novel rehabilitation intervention | In a 4-patient pediatric case series, 22 sessions over 5–8 weeks of transcutaneous spinal cord stimulation (TSS) plus gait training were feasible and safe. Session completion was 98.48%; no significant adverse events. 6MWT improved by +98.3 m, +68 m, +9.4 m, and +49.4 m; 3/4 exceeded MCID. WISCI-II improved clinically in 2/4 participants. (neighbors2024transcutaneousspinalcord pages 3-5, neighbors2024transcutaneousspinalcord pages 5-8, neighbors2024transcutaneousspinalcord pages 1-2) | Four children with incomplete SCI secondary to AFM | 2024 | Neighbors, Children | https://doi.org/10.3390/children11091116 | |
| Surgical reconstruction / prognosis | Retrospective cohort of 39 AFM patients (50 upper extremities). Recovery assessed at median 3, 6, and 37 months. Key prognostic result: none of the patients with M0 shoulder abduction at 6 months later recovered M1 or better. Twenty-seven patients (29 extremities) underwent reconstruction (nerve transfer, muscle-tendon transfer, free muscle transfer). Elbow/hand outcomes were more consistent than shoulder outcomes. (doi2024midtermoutcomesof pages 1-2, doi2024midtermoutcomesof pages 11-12, doi2024midtermoutcomesof pages 2-4) | AFM upper-extremity paralysis, 2011–2019 surgical referral cohort | 2024 | Doi, JBJS Open Access | https://doi.org/10.2106/JBJS.OA.23.00143 | |
| Case report / diagnostic illustration | First reported Belgium AFM case linked to EV-D68: 4-year-old with acute right upper-limb palsy. MRI showed central gray matter T2 hyperintensity in cervical cord C2–C7 with posterior brainstem involvement; nasopharyngeal PCR positive for EV-D68; CSF enterovirus PCR negative. Authors note poor functional prognosis and no evidence-based treatment guideline. (rodesch2024afirstcase pages 3-5, rodesch2024afirstcase pages 1-3) | Single pediatric case, Belgium | 2024 | Rodesch, Case Reports in Neurology | https://doi.org/10.1159/000535316 | |
| Prospective follow-up study / trial registry | ClinicalTrials.gov follow-up study of pediatric AFM associated with EV-D68 planned functional follow-up using Hammersmith Functional Motor Scale at 1–3 years; secondary outcomes include MRC scores, ACTIVLIM, PedsQL, ICU/mechanical ventilation duration, deaths, and complete recovery. Enrollment target 40; start date 2018-04-09. (NCT03499366 chunk 1) | European children <18 years with AFM, EV-D68 PCR positivity, MRI-confirmed myelitis | 2018 | Pfeiffer, ClinicalTrials.gov (NCT03499366) | https://clinicaltrials.gov/study/NCT03499366 |
Table: This table summarizes high-yield evidence on acute flaccid myelitis across surveillance, etiology, diagnostics, rehabilitation, surgery, and follow-up research. It is designed to support a disease knowledge base entry with recent statistics, clinically actionable findings, and source links.
References
(whitehouse2024surveillanceforacute pages 1-2): ER Whitehouse. Surveillance for acute flaccid myelitis―united states, 2018–2022. Unknown journal, 2024.
(kidd2020vitalsignsclinical pages 1-2): Sarah Kidd, Adriana Lopez, W. Allan Nix, Gloria Anyalechi, Megumi Itoh, Eileen Yee, M. Steven Oberste, and Janell Routh. Vital signs: clinical characteristics of patients with confirmed acute flaccid myelitis, united states, 2018. Morbidity and Mortality Weekly Report, 69:1031-1038, Aug 2020. URL: https://doi.org/10.15585/mmwr.mm6931e3, doi:10.15585/mmwr.mm6931e3. This article has 24 citations.
(messacar2024multimodalsurveillancemodel pages 3-5): K. Messacar, Shannon Matzinger, Kevin Berg, Kirsten Weisbeck, Molly Butler, Nicholas J Pysnack, Hai Nguyen-Tran, Emily Spence Davizon, Laura Bankers, Sarah A. Jung, Meghan C Birkholz, Allison Wheeler, and Samuel R. Dominguez. Multimodal surveillance model for enterovirus d68 respiratory disease and acute flaccid myelitis among children in colorado, usa, 2022. Emerging Infectious Diseases, 30:423-431, Mar 2024. URL: https://doi.org/10.3201/eid3003.231223, doi:10.3201/eid3003.231223. This article has 22 citations and is from a domain leading peer-reviewed journal.
(rodesch2024afirstcase pages 1-3): Marine Rodesch, Claudine Sculier, Valentina Lolli, Gauthier Remiche, Iris Delpire, Christophe Fricx, Françoise Vermeulen, and Florence Christiaens. A first case of acute flaccid myelitis related to enterovirus d68 in belgium: case report. Case Reports in Neurology, 16:41-47, Jan 2024. URL: https://doi.org/10.1159/000535316, doi:10.1159/000535316. This article has 4 citations and is from a peer-reviewed journal.
(doi2024midtermoutcomesof pages 1-2): Kazuteru Doi, Yasunori Hattori, Sotetsu Sakamoto, Dawn Sinn Yii Chia, Vijayendrasingh Gour, and Jun Sasaki. Midterm outcomes of surgical reconstruction and spontaneous recovery of upper-extremity paralysis following acute flaccid myelitis. JBJS Open Access, Apr 2024. URL: https://doi.org/10.2106/jbjs.oa.23.00143, doi:10.2106/jbjs.oa.23.00143. This article has 1 citations.
(aguglia2023contemporaryenterovirusd68isolates pages 1-2): Gabrielle Aguglia, Carolyn B. Coyne, Terence S. Dermody, John V. Williams, and Megan Culler Freeman. Contemporary enterovirus-d68 isolates infect human spinal cord organoids. mBio, Aug 2023. URL: https://doi.org/10.1128/mbio.01058-23, doi:10.1128/mbio.01058-23. This article has 22 citations and is from a domain leading peer-reviewed journal.
(rodesch2024afirstcase pages 3-5): Marine Rodesch, Claudine Sculier, Valentina Lolli, Gauthier Remiche, Iris Delpire, Christophe Fricx, Françoise Vermeulen, and Florence Christiaens. A first case of acute flaccid myelitis related to enterovirus d68 in belgium: case report. Case Reports in Neurology, 16:41-47, Jan 2024. URL: https://doi.org/10.1159/000535316, doi:10.1159/000535316. This article has 4 citations and is from a peer-reviewed journal.
(neighbors2024transcutaneousspinalcord pages 5-8): Elizabeth Neighbors, Lia Brunn, Agostina Casamento-Moran, and Rebecca Martin. Transcutaneous spinal cord stimulation enables recovery of walking in children with acute flaccid myelitis. Children, 11:1116, Sep 2024. URL: https://doi.org/10.3390/children11091116, doi:10.3390/children11091116. This article has 2 citations.
(murphy2021acuteflaccidmyelitis pages 1-2): Olwen C Murphy, Kevin Messacar, Leslie Benson, Riley Bove, Jessica L Carpenter, Thomas Crawford, Janet Dean, Roberta DeBiasi, Jay Desai, Matthew J Elrick, Raquel Farias-Moeller, Grace Y Gombolay, Benjamin Greenberg, Matthew Harmelink, Sue Hong, Sarah E Hopkins, Joyce Oleszek, Catherine Otten, Cristina L Sadowsky, Teri L Schreiner, Kiran T Thakur, Keith Van Haren, Carolina M Carballo, Pin Fee Chong, Amary Fall, Vykuntaraju K Gowda, Jelte Helfferich, Ryutaro Kira, Ming Lim, Eduardo L Lopez, Elizabeth M Wells, E Ann Yeh, Carlos A Pardo, Andrea Salazar-Camelo, Divakar Mithal, Molly Wilson-Murphy, Andrea Bauer, Colyn Watkins, Mark Abzug, Samuel Dominguez, Craig Press, Michele Yang, Nusrat Ahsan, Leigh Ramos-Platt, Emmanuelle Tiongson, Mitchel Seruya, Ann Tilton, Elana Katz, Matthew Kirschen, Apurva Shah, Erlinda Ulloa, Sabrina Yum, Lileth Mondok, Megan Blaufuss, Amy Rosenfeld, Wendy Vargas, Jason Zucker, Anusha Yeshokumar, Allison Navis, Kristen Chao, Kaitlin Hagen, Michelle Melicosta, Courtney Porter, Margaret Tunney, Richard Scheuermann, Priya Duggal, Andrew Pekosz, Amy Bayliss, Meghan Moore, Allan Belzberg, Melania Bembea, Caitlin O'Brien, Rebecca Riggs, Jessica Nance, Aaron Milstone, Jessica Rice, Maria A. Garcia-Dominguez, Eoin Flanagan, Jan-Mendelt Tillema, Glendaliz Bosques, Sonal Bhatia, Eliza Gordon-Lipkin, Dawn Deike, Gadi Revivo, Dan Zlotolow, Gabrielle deFiebre, Peggy Lazerow, Timothy Lotze, Ari Bitnun, Kristen Davidge, Jiri Vajsar, Amy Moore, Chamindra Konersman, Kendall Nash, Jonathan Strober, Nalin Gupta, Charles Chiu, Michael Sweeney, William Jackson, Dennis Simon, Kavita Thakkar, Jonathan Cheng, John Luce, Suman Das, Matthew Vogt, NgocHanh Vu, Jacqueline Gofshteyn, Naila Makhani, and Payal Patel. Acute flaccid myelitis: cause, diagnosis, and management. The Lancet, 397:334-346, Jan 2021. URL: https://doi.org/10.1016/s0140-6736(20)32723-9, doi:10.1016/s0140-6736(20)32723-9. This article has 195 citations and is from a highest quality peer-reviewed journal.
(whitehouse2024surveillanceforacute pages 5-6): ER Whitehouse. Surveillance for acute flaccid myelitis―united states, 2018–2022. Unknown journal, 2024.
(whitehouse2024surveillanceforacute pages 6-7): ER Whitehouse. Surveillance for acute flaccid myelitis―united states, 2018–2022. Unknown journal, 2024.
(whitehouse2024surveillanceforacute pages 4-5): ER Whitehouse. Surveillance for acute flaccid myelitis―united states, 2018–2022. Unknown journal, 2024.
(vawterlee2021acuteflaccidmyelitis pages 2-3): Marissa Vawter-Lee, Katrina Peariso, Mary Frey, Priya Bolikal, Joshua K. Schaffzin, Ann Schwentker, William T. O’Brien, Ronine Zamor, and Benjamin T. Kerrey. Acute flaccid myelitis: a multidisciplinary protocol to optimize diagnosis and evaluation. Journal of Child Neurology, 36:421-431, Dec 2021. URL: https://doi.org/10.1177/0883073820975230, doi:10.1177/0883073820975230. This article has 10 citations and is from a peer-reviewed journal.
(aguglia2023contemporaryenterovirusd68isolates pages 5-8): Gabrielle Aguglia, Carolyn B. Coyne, Terence S. Dermody, John V. Williams, and Megan Culler Freeman. Contemporary enterovirus-d68 isolates infect human spinal cord organoids. mBio, Aug 2023. URL: https://doi.org/10.1128/mbio.01058-23, doi:10.1128/mbio.01058-23. This article has 22 citations and is from a domain leading peer-reviewed journal.
(aguglia2023contemporaryenterovirusd68isolates pages 2-5): Gabrielle Aguglia, Carolyn B. Coyne, Terence S. Dermody, John V. Williams, and Megan Culler Freeman. Contemporary enterovirus-d68 isolates infect human spinal cord organoids. mBio, Aug 2023. URL: https://doi.org/10.1128/mbio.01058-23, doi:10.1128/mbio.01058-23. This article has 22 citations and is from a domain leading peer-reviewed journal.
(aguglia2023contemporaryenterovirusd68isolates pages 8-10): Gabrielle Aguglia, Carolyn B. Coyne, Terence S. Dermody, John V. Williams, and Megan Culler Freeman. Contemporary enterovirus-d68 isolates infect human spinal cord organoids. mBio, Aug 2023. URL: https://doi.org/10.1128/mbio.01058-23, doi:10.1128/mbio.01058-23. This article has 22 citations and is from a domain leading peer-reviewed journal.
(aguglia2023contemporaryenterovirusd68isolates pages 10-12): Gabrielle Aguglia, Carolyn B. Coyne, Terence S. Dermody, John V. Williams, and Megan Culler Freeman. Contemporary enterovirus-d68 isolates infect human spinal cord organoids. mBio, Aug 2023. URL: https://doi.org/10.1128/mbio.01058-23, doi:10.1128/mbio.01058-23. This article has 22 citations and is from a domain leading peer-reviewed journal.
(dabilla2025strainspecifictropismand pages 9-10): Nathânia Dábilla, Sarah Maya, Colton McNinch, Taylor Eddens, Patrick T. Dolan, and Megan Culler Freeman. Strain-specific tropism and transcriptional responses of enterovirus d68 infection in human spinal cord organoids. Frontiers in Microbiology, Nov 2025. URL: https://doi.org/10.3389/fmicb.2025.1698639, doi:10.3389/fmicb.2025.1698639. This article has 6 citations and is from a peer-reviewed journal.
(ide2021acuteflaccidmyelitis. pages 11-13): William Ide, Michelle Melicosta, and Melissa K. Trovato. Acute flaccid myelitis. Physical medicine and rehabilitation clinics of North America, 32 3:477-491, Aug 2021. URL: https://doi.org/10.1016/j.pmr.2021.02.004, doi:10.1016/j.pmr.2021.02.004. This article has 15 citations and is from a peer-reviewed journal.
(messacar2024multimodalsurveillancemodel pages 5-7): K. Messacar, Shannon Matzinger, Kevin Berg, Kirsten Weisbeck, Molly Butler, Nicholas J Pysnack, Hai Nguyen-Tran, Emily Spence Davizon, Laura Bankers, Sarah A. Jung, Meghan C Birkholz, Allison Wheeler, and Samuel R. Dominguez. Multimodal surveillance model for enterovirus d68 respiratory disease and acute flaccid myelitis among children in colorado, usa, 2022. Emerging Infectious Diseases, 30:423-431, Mar 2024. URL: https://doi.org/10.3201/eid3003.231223, doi:10.3201/eid3003.231223. This article has 22 citations and is from a domain leading peer-reviewed journal.
(doi2024midtermoutcomesof pages 12-13): Kazuteru Doi, Yasunori Hattori, Sotetsu Sakamoto, Dawn Sinn Yii Chia, Vijayendrasingh Gour, and Jun Sasaki. Midterm outcomes of surgical reconstruction and spontaneous recovery of upper-extremity paralysis following acute flaccid myelitis. JBJS Open Access, Apr 2024. URL: https://doi.org/10.2106/jbjs.oa.23.00143, doi:10.2106/jbjs.oa.23.00143. This article has 1 citations.
(doi2024midtermoutcomesof pages 11-12): Kazuteru Doi, Yasunori Hattori, Sotetsu Sakamoto, Dawn Sinn Yii Chia, Vijayendrasingh Gour, and Jun Sasaki. Midterm outcomes of surgical reconstruction and spontaneous recovery of upper-extremity paralysis following acute flaccid myelitis. JBJS Open Access, Apr 2024. URL: https://doi.org/10.2106/jbjs.oa.23.00143, doi:10.2106/jbjs.oa.23.00143. This article has 1 citations.
(neighbors2024transcutaneousspinalcord pages 1-2): Elizabeth Neighbors, Lia Brunn, Agostina Casamento-Moran, and Rebecca Martin. Transcutaneous spinal cord stimulation enables recovery of walking in children with acute flaccid myelitis. Children, 11:1116, Sep 2024. URL: https://doi.org/10.3390/children11091116, doi:10.3390/children11091116. This article has 2 citations.
(NCT03499366 chunk 1): Helle Cecilie Viekilde Pfeiffer. European Paediatric AFM Associated With EV-D68 Follow-up Study.. Oslo University Hospital. 2018. ClinicalTrials.gov Identifier: NCT03499366
(messacar2024multimodalsurveillancemodel pages 7-8): K. Messacar, Shannon Matzinger, Kevin Berg, Kirsten Weisbeck, Molly Butler, Nicholas J Pysnack, Hai Nguyen-Tran, Emily Spence Davizon, Laura Bankers, Sarah A. Jung, Meghan C Birkholz, Allison Wheeler, and Samuel R. Dominguez. Multimodal surveillance model for enterovirus d68 respiratory disease and acute flaccid myelitis among children in colorado, usa, 2022. Emerging Infectious Diseases, 30:423-431, Mar 2024. URL: https://doi.org/10.3201/eid3003.231223, doi:10.3201/eid3003.231223. This article has 22 citations and is from a domain leading peer-reviewed journal.
(neighbors2024transcutaneousspinalcord pages 3-5): Elizabeth Neighbors, Lia Brunn, Agostina Casamento-Moran, and Rebecca Martin. Transcutaneous spinal cord stimulation enables recovery of walking in children with acute flaccid myelitis. Children, 11:1116, Sep 2024. URL: https://doi.org/10.3390/children11091116, doi:10.3390/children11091116. This article has 2 citations.
(doi2024midtermoutcomesof pages 2-4): Kazuteru Doi, Yasunori Hattori, Sotetsu Sakamoto, Dawn Sinn Yii Chia, Vijayendrasingh Gour, and Jun Sasaki. Midterm outcomes of surgical reconstruction and spontaneous recovery of upper-extremity paralysis following acute flaccid myelitis. JBJS Open Access, Apr 2024. URL: https://doi.org/10.2106/jbjs.oa.23.00143, doi:10.2106/jbjs.oa.23.00143. This article has 1 citations.
Acute flaccid myelitis (AFM) is a rare but serious neurologic condition characterized by the acute onset of flaccid limb weakness with magnetic resonance imaging (MRI) evidence of spinal cord gray matter lesions. It primarily affects children and has been described as a "polio-like" illness due to striking clinical similarities to poliomyelitis (PMID: 32143233). AFM was first recognized as a distinct clinical entity in 2012 when a cluster of acute flaccid paralysis cases of unknown etiology was identified in California (PMID: 26720027). The US Centers for Disease Control and Prevention (CDC) began national surveillance in 2014 following 120 confirmed cases (PMID: 38300829).
Disease-level characterization is derived from aggregated surveillance data (CDC national AFM surveillance, European Non-Polio Enterovirus Network [ENPEN]), multicenter clinical cohorts, population-based studies (e.g., Kaiser Permanente Northern California), and individual patient case series.
AFM is an infectious/post-infectious neurologic disease. The primary causal agent is Enterovirus D68 (EV-D68), a non-polio enterovirus belonging to the Enterovirus genus, species Enterovirus D, family Picornaviridae.
Evidence for EV-D68 causation: - Temporal correlation: Biennial peaks in AFM cases (2014, 2016, 2018) coincided with increased EV-D68 respiratory circulation (PMID: 38300829). - In Europe, 70% of AFM cases (n=91/130) occurred in years of increased EV-D68 circulation (2016, 2018, 2022), and 37% (48/130) were EV-D68 laboratory-confirmed (PMID: 40444374). - Mouse models fulfill Koch's postulates: EV-D68 2014 outbreak strains cause paralytic myelitis with infection and loss of spinal cord motor neurons in neonatal mice (PMID: 28231269). - A systematic review and meta-analysis confirmed the association between EV-D68 detection and acute neurologic outcomes (PMID: 42066114).
Other viruses have been associated with AFM in smaller numbers, including: - Enterovirus A71 (EV-A71) - Coxsackieviruses (A and B) - West Nile virus (PMID: 40622703) - Adenoviruses - Other non-polio enteroviruses
Search source: PubMed, CDC, population-based studies
No specific human genetic susceptibility loci have been identified for AFM. The disease is not a Mendelian disorder. Host genetic factors influencing susceptibility remain an area of active investigation. The association with atopy/asthma suggests possible immune genetic modifiers.
The interaction between host immune status (particularly innate interferon responses) and viral exposure determines disease outcome. The respiratory epithelium induces a robust type III interferon response that restricts EV-D68 infection, while intestinal epithelium does not (PMID: 34196272). Children with asthma/atopy may have altered antiviral immune responses that increase susceptibility to severe EV-D68 disease.
AFM is not caused by human genetic mutations. The causal genetic elements are viral:
No specific epigenetic alterations have been reported for AFM susceptibility in host cells.
Not applicable; AFM is not associated with chromosomal abnormalities.
No specific lifestyle factors have been identified beyond the association with atopy/asthma, which may reflect underlying immune phenotype rather than modifiable lifestyle factors.
Primary agent: - Enterovirus D68 (EV-D68) - NCBI Taxonomy: TaxID 42789 - Family: Picornaviridae - Genus: Enterovirus - Species: Enterovirus D - Genome: Positive-sense single-stranded RNA (~7.4 kb) - First isolated: 1962 from children with pneumonia (Fermon strain) - Unique among enteroviruses: resembles human rhinoviruses in acid lability and temperature sensitivity (PMID: 41868141)
Other associated agents: - Enterovirus A71 (EV-A71) - NCBI TaxID 39054 - Coxsackieviruses (A and B species) - West Nile virus (rare AFM cause in adults) - Adenoviruses (rarely)
The pathophysiological cascade of AFM proceeds through the following steps:
1. Respiratory Entry and Replication (Upstream) - EV-D68 enters via the respiratory tract, binding to α2,6-linked sialic acid and/or MFSD6 on respiratory epithelial cells (PMID: 41467840) - Viral replication in the respiratory epithelium triggers a type III interferon response (PMID: 34196272) - The virus can use clathrin-mediated endocytosis and compensatory macropinocytosis for entry (PMID: 42037410)
2. Systemic/Neural Spread (Intermediate) - EV-D68 spreads from respiratory tract to the central nervous system, likely via retrograde axonal transport from infected skeletal muscle to spinal cord motor neurons - In mouse models, skeletal muscle and spinal cord had the highest viral titers (PMID: 41305500) - Viremia may also contribute to neural spread
3. Motor Neuron Infection (Intermediate) - EV-D68 binds ICAM-5 (neuron-specific receptor) for entry into spinal cord motor neurons (PMID: 41467840) - Viral replication in motor neurons of the anterior horn cells - GO terms: GO:0019058 (viral life cycle), GO:0044409 (entry into host cell)
4. Cell Death and Immune-Mediated Damage (Downstream) - Direct cytopathology: EV-D68 infection causes motor neuron death through: - Mitochondrial dysfunction: EV-D68 3C protease cleaves Mitofusin 2, causing mitochondrial fragmentation (PMID: 42018625) - Oxidative stress: RNA-seq of infected spinal cords shows mitochondrial dysfunction and oxidative stress pathways (PMID: 41305500) - GO terms: GO:0008219 (cell death), GO:0006915 (apoptosis)
5. Motor Neuron Loss and Clinical Paralysis (Downstream) - Loss of anterior horn motor neurons produces lower motor neuron paralysis - Wallerian degeneration of motor axons follows - Clinical manifestation as acute flaccid limb weakness - CL terms: CL:0011001 (spinal cord motor neuron), CL:0000100 (motor neuron) - UBERON terms: UBERON:0002257 (ventral horn of spinal cord), UBERON:0014621 (cervical spinal cord ventral horn)
Reactome: R-HSA-913531 (Interferon Signaling)
Autophagy/Mitophagy: EV-D68 induces nonselective autophagy and mitophagy via Mitofusin 2 cleavage; mitophagosomes serve as vectors for nonlytic viral release (PMID: 42018625)
GO: GO:0006914 (autophagy), GO:0000422 (autophagy of mitochondria)
NF-kB/TRAF3 pathway: EV-D68 2A protease cleaves TRAF3 to evade innate immunity (PMID: 41600837)
Reactome: R-HSA-975138 (TRAF6-mediated NF-kB activation)
Cytokine signaling: DEGs enriched in cytokine-cytokine receptor interaction and JAK-STAT pathways (PMID: 41305500)
EV-D68 employs a multi-layered immune evasion strategy targeting the type I IFN pathway at three distinct nodes:
VP3-MAVS interaction (receptor-proximal): VP3 structural protein co-localizes and interacts with MAVS, disrupts mitochondrial membrane potential, releases MAVS from mitochondria, and inhibits NF-kB signaling. VP3 binds to the transmembrane domain of MAVS. This is a broad-spectrum enterovirus strategy (PMID: 40042308).
3C protease-STAT1 cleavage (downstream signaling): EV-D68 3C protease cleaves STAT1 at the 131Q residue, abolishing STAT1 nuclear translocation and attenuating IFN signal transduction. Notably, this ability is shared with poliovirus 3C protease but NOT with EV-A71, CVA16, or echoviruses — potentially explaining the shared polio-like phenotype between EV-D68 and poliovirus (PMID: 38240591).
USP5 deubiquitinase exploitation (upstream of IFN induction): EV-D68 infection upregulates USP5, which reduces K63-linked polyubiquitination of MAVS and IRF3, decreasing IFN-I production. Pharmacological USP5 inhibition with PR-619 potentiated antiviral IFN effects, suggesting a therapeutic target (PMID: 41352537).
3C protease-MDA5 disruption: EV-D68 3C protein cleaves MDA5, a key cytoplasmic viral RNA sensor, disrupting innate immune detection of viral RNA (PMID: 28424289).
Mechano-Antiviral Response System (MARS) via Piezo1: Cellular compression or fluid pressure activates Piezo1-dependent antiviral resistance by reducing host cell membrane fluidity, restricting viral entry. Piezo1 agonists or mechanical stimuli alleviate EV-D68-induced neurological damage and lethality in vivo. This represents a non-canonical antiviral strategy distinct from interferon signaling (PMID: 41650963).
STING hijacking for replication organelles: EV-D68 hijacks STING (stimulator of interferon genes) for a non-canonical, pro-viral function — formation of specialized lipid replication organelles (ROs). STING co-localizes with glycolytic enzymes within ROs, and its inhibition modulates glucose metabolism in infected cells. This reveals that STING has dual roles: canonical antiviral DNA sensing AND non-canonical pro-viral membrane remodeling exploited by RNA viruses (PMID: 39459875).
ARRDC3-YAP antiviral pathway: Enterovirus infection induces ARRDC3 (Arrestin Domain Containing 3), which promotes lysosomal degradation of YAP (Yes-associated protein). YAP facilitates enterovirus replication by suppressing the interferon pathway during later stages of infection. The ARRDC3-YAP axis exhibits broad-spectrum antiviral activity (PMID: 40701343).
TRIM25 restoration of RIG-I: EV-D68 3C protease reduces both RIG-I and TRIM25 expression. Overexpression of TRIM25 restores RIG-I expression and IFN-β production, suggesting TRIM25 as a potential therapeutic target (PMID: 34170466).
Primary organs: - Spinal cord (UBERON:0002240) - Primary site of pathology; gray matter predominantly affected - Skeletal muscle (UBERON:0001134) - Secondary to denervation and direct viral infection
Secondary organ involvement: - Brain/brainstem (UBERON:0002298) - Brainstem involvement with cranial nerve nuclei in some cases; posterior brainstem T2 signal changes reported (PMID: 38405019) - Lungs (UBERON:0002048) - Respiratory failure due to diaphragm paralysis; respiratory tract as primary site of viral entry - Bladder (UBERON:0001255) - Autonomic dysfunction with urinary retention
Body systems involved: - Nervous system (central and peripheral) - Respiratory system - Musculoskeletal system - Autonomic nervous system
Recovery phase (months to years): Slow, incomplete recovery in most patients
Progression rate: Rapid to nadir; much faster than GBS (3 vs 8 days, p<0.001) (PMID: 34747551)
KPNC population-based estimate: 1.46 per 100,000 person-years (children 1-18 years, 2011-2016) (PMID: 30985511)
Europe: 130 reported cases across 14 countries (2016-2023), though significant underreporting suspected due to lack of systematic surveillance in most countries (PMID: 40444374)
LOINC: 26465-7 (WBC count in CSF)
Respiratory specimen RT-PCR:
LOINC: 92141-1 (Enterovirus D68 RNA in specimen by NAA)
Stool specimen: For enterovirus detection; lower yield for EV-D68 than for other enteroviruses
95% sensitivity for confirmed AFM (PMID: 26720027)
Brain MRI:
A Dutch cohort study evaluating AFM diagnostic criteria in 141 children with acute limb weakness found: - Only 7/9 patients initially classified as "definite AFM" retained this label after expert review - Patients initially classified as probable/possible AFM were most commonly re-diagnosed with transverse myelitis (16/25) - When initial classification was "uncertain," GBS was the most common final diagnosis (31/43) - Highlights the challenge of early AFM diagnosis and the importance of expert neurological evaluation
Key conditions to distinguish from AFM (PMID: 32143233, PMID: 34747551, PMID: 31338675):
| Condition | Distinguishing Features |
|---|---|
| Guillain-Barre syndrome (GBS) | Symmetric weakness; longer time to nadir (8 vs 3 days); sensory deficits (40% vs 0%); elevated CSF protein; demyelinating pattern on NCS; no spinal cord MRI lesions |
| Transverse myelitis | White matter > gray matter on MRI; sensory level; autoimmune markers; responds to immunotherapy |
| Spinal cord stroke | Hyperacute onset; vascular risk factors; anterior spinal artery distribution |
| Poliomyelitis | Similar presentation; poliovirus detected; travel/exposure history |
| MOG-antibody myelitis | MOG-IgG positive; longitudinally extensive T2 lesion; responds to immunotherapy; may relapse (PMID: 30575890) |
| Spinal cord tumor | Progressive rather than acute; mass lesion on MRI |
3-Year Follow-up (Japan, n=33) (PMID: 33388543): - Complete recovery rates by initial severity: tetraplegia/triplegia 2/7 (29%), paraplegia 4/13 (31%), monoplegia 2/13 (15%) - 27% showed continued improvement between 6-month and 3-year timepoints - Barthel index significantly improved at chronic stage (P<0.001; median difference 53, 95% CI: 40-63) - All 6 EV-D68-positive patients had persistent motor deficits - Non-motor neurological findings (cranial nerves, sensory) had better prognosis than motor weakness
1-Year Follow-up (Colorado, n=12) (PMID: 28615421): - 6/8 completing study had persistent motor deficits; 2 fully recovered - Proximal muscles: minimal to no improvement with significant atrophy - Distal muscles: all patients improved - Cranial nerve dysfunction: resolved in 2/5, improved in all - Repeat MRI showed significant improvement or normalization in all but one - Repeat EMG: ongoing denervation and chronic reinnervation in those with persistent deficits - Pain: 2/8 at 1 year; depressive symptoms: 3/8
Long-term Respiratory Outcomes (KPNC, n=37, median 4.7 years follow-up) (PMID: 39657203): - 21.6% had respiratory failure during index hospitalization - Among those with respiratory failure, 75% required follow-up respiratory support - Respiratory failure associated with: higher Modified Rankin Scores (mean diff 1.29, 95% CI: 0.34-2.23), higher respiratory-related ED visits (IRR 1.94, 95% CI: 1.27-2.96) - Overall AFM incidence: 0.6 per 100,000 person-years
Texas Cohort (n=21, ~2 years follow-up) (PMID: 32192819): - 5 fully recovered; 5 able to perform all ADLs independently; 5 mild deficits; 6 substantial caregiver reliance - No treatment differences detected (IVIG, steroids, plasmapheresis all used)
Abundant acute denervation potentials on EMG (PMID: 37981447)
Better prognosis:
No FDA-approved treatments exist for AFM. Management is primarily supportive with empirical immunomodulatory therapies.
MAXO: MAXO:0001298 (intravenous immunoglobulin therapy)
Corticosteroids:
MAXO: MAXO:0000609 (corticosteroid therapy)
Therapeutic plasma exchange (TPE) / Plasmapheresis:
MAXO: MAXO:0001077 (plasmapheresis)
Fluoxetine:
No antivirals are currently approved; several candidates are in development:
Reduce spinal cord viral titer, prevent paralysis progression in mice even when treatment initiated 4-6 days post-infection (PMID: 41667472)
2C helicase inhibitors (Jun6504):
Significantly improves paralysis score in neonatal mouse model (PMID: 40593720)
Orally available peptidomimetic 2C inhibitor (2CA-1):
Excellent oral bioavailability; broad enterovirus activity (PMID: 41485562)
Fluoxetine analogues (compound 53):
Optimized from (S)-fluoxetine targeting 2C ATPase; improved potency (PMID: 41621223)
VP1 protein degraders (PROTACs):
Targeted protein degradation strategy to overcome capsid inhibitor resistance (PMID: 42063851)
Matrine (natural product):
Alkaloid with broad-spectrum antiviral activity via autophagy activation (PMID: 41205525)
Geranyl-p-trans-coumaric acid (GCA):
Natural product EV-D68 inhibitor (PMID: 41175053)
RNA-encoded VHH antibodies:
No vaccines are approved; multiple platforms in development:
mRNA expressing EV-D68 virus-like particles elicited potent neutralizing antibodies superior to inactivated whole virion vaccine; protective in mice; also attenuated CVB3 infection (PMID: 41210583)
Self-amplifying RNA (saRNA) vaccine:
Clinical-stage RNA vaccine platform induced robust EV-D68-neutralizing antibody responses in both mice and nonhuman primates; prevented upper and lower respiratory tract infections and neurological disease in mice. Characterized antigenic diversity across six EV-D68 genotypes to inform multivalent vaccine composition for optimal breadth of neutralizing responses. Represents proof-of-concept for RNA vaccines against nonenveloped viruses (PMID: 39110777).
Inactivated whole virion vaccine:
Formalin-inactivated EV-D68 from serum-free HEK293A suspension culture; induced neutralizing responses including against recent circulating strains (PMID: 42086005)
Multi-epitope vaccine (in silico):
Upper extremity reconstruction (PMID: 38774108): - Study of 39 patients, 50 upper extremities (2011-2019) - Patients with complete paralysis of shoulder abduction at 6 months showed no later spontaneous recovery - 22 patients (24 extremities) underwent shoulder surgery: nerve transfer, muscle-tendon transfer, or free muscle transfer - Both spinal accessory nerve transfer and contralateral C7 nerve root transfer to suprascapular nerve gave similar shoulder abduction recovery - MAXO: MAXO:0000014 (surgical procedure)
Rehabilitation following nerve transfer (PMID: 33016189): - Interdisciplinary team approach: OT, PT, surgical team, family - Pre-operative and six phases of post-operative therapy recommended - Addresses: assessment, strengthening, range of motion, orthoses, functional activities, family support - Communication between team members identified as vital - MAXO: MAXO:0000502 (physical therapy), MAXO:0001351 (occupational therapy)
Functional outcomes (WeeFIM) (PMID: 32677590): - Inpatient rehabilitation with neuropsychological evaluation - Admission and discharge WeeFIM scores showed deficits most pronounced in self-care and mobility domains - Multiple nerve transfer surgery performed on 13 limbs in 6 children; AMS improvement in 4 of 6
Key models: 1. Neonatal Swiss Webster IM model (PMID: 28231269): - US/MO/14-18947 and US/IL/14-18952 strains cause progressive paralysis - Viral infection and loss of motor neurons in anterior horns - Fulfills Koch's postulates - Used for therapeutic evaluation
Recapitulates both respiratory and neurologic disease
Mouse-adapted EV-D68 IM model (PMID: 41305500):
Spinal cord and skeletal muscle as highest titer tissues
Neonatal IFNAR-/- IP model (PMID: 32784424):
Histopathologic changes (neuronal necrosis, inflammation)
Limitations:
Acute flaccid myelitis (AFM) is a rare, devastating neurologic condition primarily affecting children, characterized by acute-onset flaccid paralysis with spinal cord gray matter involvement on MRI. The disease is strongly associated with Enterovirus D68 (EV-D68) infection, with biennial outbreak patterns observed in the United States from 2014-2018 (disrupted by COVID-19 pandemic NPIs and confirmed through wastewater surveillance showing September peak seasonality).
Viral entry and neurotropism: EV-D68 neurotropism is mediated through multiple receptor interactions (sialic acid, ICAM-5, MFSD6), with the VP1 capsid protein as the primary determinant of neurovirulence. The virus hijacks STING for formation of specialized lipid replication organelles and exploits host immunometabolism.
Immune evasion and host defense: The virus employs multi-layered immune evasion: VP3-MAVS disruption, 3C-STAT1 cleavage (shared with poliovirus), USP5 deubiquitinase exploitation, and 3C-mediated RIG-I/TRIM25 degradation to suppress type I IFN signaling. Host defense mechanisms include the novel Piezo1-mediated mechano-antiviral response system (MARS) that restricts viral entry through membrane remodeling, and the ARRDC3-YAP pathway. CSF biomarkers IP-10 and IL-6 are elevated in AFM, reflecting intrathecal neuroinflammation.
Pathogenesis: Both direct viral cytopathology of anterior horn motor neurons and immune-mediated secondary injury (mitochondrial dysfunction via MFN2 cleavage, oxidative stress, CD8+ T cell infiltration) contribute to motor neuron destruction.
Critical unresolved question: EV-D68 respiratory outbreaks in 2022 and 2024 were NOT accompanied by AFM surges despite the prior biennial correlation (2014-2018). Global seroprevalence data show ~100% seropositivity by age 20, suggesting near-universal exposure. Possible explanations for the AFM-EV-D68 dissociation include viral genomic evolution (novel B3-derived lineages, A2/D reemergence), altered population immunity post-pandemic, and mutations in key neurovirulence determinants.
Management and outcomes: No approved treatments or vaccines exist; management relies on supportive care, empirical immunotherapy (IVIG, plasmapheresis), and comprehensive surgical reconstruction (nerve, tendon, and free muscle transfers) for persistent weakness. Long-term follow-up shows functional independence improves over years (Barthel index P<0.001), but motor deficits persist in the majority, with respiratory failure at presentation predicting worse outcomes. The prognosis remains poor, with <10% achieving full recovery. Active development of VP1 capsid inhibitors, 2C helicase inhibitors, Piezo1 agonists, self-amplifying RNA vaccines, and mRNA VLP vaccines offers hope for future therapeutic and preventive options.
| PMID | Key Contribution |
|---|---|
| 32143233 | Comprehensive clinical review of AFM |
| 38300829 | CDC surveillance 2018-2022 |
| 40444374 | European AFM epidemiology |
| 28231269 | Mouse model fulfilling Koch's postulates |
| 38869283 | VP1 as neurovirulence determinant |
| 41467840 | Receptor biology (ICAM-5, MFSD6) |
| 42018625 | Mitofusin 2 cleavage mechanism |
| 41305500 | Spinal cord RNA-seq pathogenesis |
| 37535397 | Human spinal cord organoid model |
| 28968718 | Preclinical therapeutic evaluation |
| 34747551 | AFM vs GBS differentiation |
| 30985511 | Population-based incidence and risk factors |
| 41667472 | VP1 capsid inhibitor development |
| 41210583 | mRNA VLP vaccine |
| 37981447 | Nerve transfer surgery outcomes |
| 41251130 | Plasmapheresis in pediatric AFM |
| 34735423 | CDC surveillance 2018-2020 |
| 41868141 | EV-D68 virology and therapeutic review |
| 41600837 | EV-D68 genomic virulence determinants |
| 30985511 | Risk factors: male sex, asthma, Asian ancestry |
| 33388543 | 3-year longitudinal motor outcomes (Japan) |
| 28615421 | 1-year outcomes including psychosocial impact (Colorado) |
| 39657203 | Long-term respiratory outcomes (4.7-year follow-up) |
| 32192819 | Texas cohort treatment and functional outcomes |
| 40042308 | VP3-MAVS immune evasion mechanism |
| 38240591 | 3C protease cleaves STAT1 for IFN evasion |
| 41352537 | USP5 deubiquitinase in enterovirus immune evasion |
| 32492201 | EV-D68 seroprevalence in Beijing |
| 32836175 | CSF cytokine biomarkers (IP-10, IL-6) in AFM |
| 41650963 | Piezo1/MARS mechano-antiviral defense |
| 39459875 | STING hijacking for replication organelles |
| 40701343 | ARRDC3-YAP antiviral pathway |
| 34170466 | TRIM25 restoration of RIG-I against EV-D68 |
| 39332429 | Global age-stratified EV-D68 seroprevalence review |
| 41853773 | US wastewater EV-D68 longitudinal surveillance |
| 36996587 | Evaluation of AFM diagnostic criteria (Netherlands) |
| 39110777 | Self-amplifying RNA vaccine (mouse + NHP) |
| Ontology | ID | Label |
|---|---|---|
| MONDO | MONDO:0100115 | acute flaccid myelitis |
| MONDO | MONDO:0005747 | enterovirus infectious disease |
| ICD-10 | G04.82 | Acute flaccid myelitis |
| MeSH | D000080524 | Myelitis, Acute Flaccid |
| HPO ID | Label | Frequency in AFM |
|---|---|---|
| HP:0012486 | Myelitis | 100% (defining) |
| HP:0003690 | Limb muscle weakness | 100% (defining) |
| HP:0002398 | Degeneration of anterior horn cells | ~100% (pathological basis) |
| HP:0006802 | Abnormal anterior horn cell morphology | ~100% |
| HP:0001252 | Hypotonia | ~100% |
| HP:0001284 | Areflexia | ~90% (affected limbs) |
| HP:0012229 | CSF pleocytosis | 50-73% |
| HP:0002878 | Respiratory failure | ~21-30% |
| HP:0006824 | Cranial nerve paralysis | ~20-30% |
| HP:0000016 | Urinary retention | Variable |
| HP:0003326 | Myalgia | ~70% (prodromal/concurrent) |
| HP:0003202 | Skeletal muscle atrophy | Common (chronic phase) |
| HP:0002015 | Dysphagia | Variable (bulbar involvement) |
| UBERON ID | Label |
|---|---|
| UBERON:0002257 | ventral horn of spinal cord |
| UBERON:0014621 | cervical spinal cord ventral horn |
| UBERON:0002315 | gray matter of spinal cord |
| UBERON:0002726 | cervical spinal cord |
| UBERON:0001884 | phrenic nerve |
| UBERON:0002240 | spinal cord |
| UBERON:0001134 | skeletal muscle tissue |
| CL ID | Label |
|---|---|
| CL:0011001 | spinal cord motor neuron |
| CL:0000100 | motor neuron |
| CL:0002368 | respiratory tract epithelial cell |
| GO ID | Label |
|---|---|
| GO:0046718 | symbiont entry into host cell |
| GO:0045087 | innate immune response |
| GO:0060337 | type I interferon-mediated signaling pathway |
| GO:0060339 | negative regulation of type I interferon-mediated signaling pathway |
| GO:0000266 | mitochondrial fission |
| GO:0006914 | autophagy |
| GO:0000422 | autophagy of mitochondrion |
| GO:0006915 | apoptotic process |
| GO:0006954 | inflammatory response |
| GO:0006979 | response to oxidative stress |
| GO:0071260 | cellular response to mechanical stimulus |
| GO:0019058 | viral life cycle |
| CHEBI ID | Label | Role in AFM |
|---|---|---|
| CHEBI:26667 | sialic acid | EV-D68 attachment factor |
| CHEBI:5118 | fluoxetine | Investigated antiviral (no efficacy in mouse model) |
| CHEBI:41879 | dexamethasone | Corticosteroid (worsened outcomes in mouse model) |
| CHEBI:24579 | immunoglobulin G | IVIG therapy (empirical treatment) |
| MAXO ID | Label |
|---|---|
| MAXO:0001298 | intravenous immunoglobulin therapy |
| MAXO:0000609 | corticosteroid therapy |
| MAXO:0001077 | plasmapheresis |
| MAXO:0000014 | surgical procedure (nerve transfer) |
| MAXO:0000502 | physical therapy |
| MAXO:0001001 | respiratory support |
| Gene Symbol | HGNC ID | Role in AFM |
|---|---|---|
| ICAM5 | HGNC:5348 | Neuron-specific EV-D68 receptor |
| MFSD6 | HGNC:24711 | Essential EV-D68 entry receptor |
| MFN2 | HGNC:16877 | Cleaved by 3C protease; mitochondrial fission |
| MAVS | HGNC:29233 | Targeted by VP3 for immune evasion |
| STAT1 | HGNC:11362 | Cleaved by 3C protease; IFN signaling |
| TRAF3 | HGNC:12033 | Cleaved by 2A protease; NF-kB pathway |
| USP5 | HGNC:12628 | Exploited by EV-D68 to suppress IFN |
| IRF3 | HGNC:6118 | De-ubiquitinated via USP5; IFN induction |
| IRF7 | HGNC:6122 | Targeted by VP3 for IFN suppression |
| PIEZO1 | HGNC:13680 | Mechano-antiviral response (MARS); membrane remodeling |
| STING1 (TMEM173) | HGNC:27962 | Hijacked for replication organelle formation |
| ARRDC3 | HGNC:28633 | Host antiviral factor; degrades YAP via lysosome |
| TRIM25 | HGNC:10544 | E3 ubiquitin ligase; restores RIG-I expression |
| YAP1 | HGNC:16262 | Facilitates enterovirus replication; suppresses IFN |